WO2021034980A1 - Non-animal based protein sources with functional properties - Google Patents

Non-animal based protein sources with functional properties Download PDF

Info

Publication number
WO2021034980A1
WO2021034980A1 PCT/US2020/047076 US2020047076W WO2021034980A1 WO 2021034980 A1 WO2021034980 A1 WO 2021034980A1 US 2020047076 W US2020047076 W US 2020047076W WO 2021034980 A1 WO2021034980 A1 WO 2021034980A1
Authority
WO
WIPO (PCT)
Prior art keywords
rova
composition
egg
food product
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2020/047076
Other languages
English (en)
French (fr)
Inventor
Kritika MAHADEVAN
Farnoosh AYOUGHI
Isha JOSHI
Joel Andrew KREPS
Harshal KSHIRSAGAR
Frank Douglas Ivey
Weixi ZHONG
Eric Lin
Alexandre CHAPEAUX
Sridharan GOVIND
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Every Co
Original Assignee
Clara Foods Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=74659544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2021034980(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to CN202080073303.XA priority Critical patent/CN114599234A/zh
Priority to AU2020331967A priority patent/AU2020331967A1/en
Priority to CA3145805A priority patent/CA3145805A1/en
Priority to HRP20250291TT priority patent/HRP20250291T1/hr
Priority to GB2203397.1A priority patent/GB2605017B/en
Priority to EP20855636.5A priority patent/EP4017287B1/en
Priority to KR1020227009006A priority patent/KR20220047845A/ko
Priority to JP2022510139A priority patent/JP2022546260A/ja
Priority to ES20855636T priority patent/ES3014359T3/es
Priority to MX2022002051A priority patent/MX2022002051A/es
Priority to EP24218433.1A priority patent/EP4559323A3/en
Application filed by Clara Foods Co filed Critical Clara Foods Co
Priority to BR112022003241A priority patent/BR112022003241A2/pt
Priority to FIU20234006U priority patent/FI13394Y1/fi
Priority to FI20225221A priority patent/FI20225221A1/en
Publication of WO2021034980A1 publication Critical patent/WO2021034980A1/en
Priority to US17/508,064 priority patent/US20220039443A1/en
Priority to IL290550A priority patent/IL290550A/en
Anticipated expiration legal-status Critical
Priority to DKPA202270112A priority patent/DK182004B1/en
Priority to US18/045,425 priority patent/US20230189857A1/en
Priority to US18/614,611 priority patent/US12096784B2/en
Priority to US18/766,643 priority patent/US20250212928A1/en
Priority to JP2025065554A priority patent/JP2025100711A/ja
Priority to US19/288,654 priority patent/US20260020590A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/40—Products characterised by the type, form or use
    • A21D13/44—Pancakes or crêpes
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/50—Solidified foamed products, e.g. meringues
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/18—Carbohydrates
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/18—Carbohydrates
    • A21D2/185—Biosynthetic gums
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/18—Carbohydrates
    • A21D2/186—Starches; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A21D2/262—Animal proteins from eggs
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/264—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/267—Microbial proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/008—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/08—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/18—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from yeasts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/20—Proteins from microorganisms or unicellular algae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/22—Working-up of proteins for foodstuffs by texturising
    • A23J3/225—Texturised simulated foods with high protein content
    • A23J3/227—Meat-like textured foods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/70—Germinated pulse products, e.g. from soy bean sprouts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A23L15/35—Egg substitutes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/03—Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60—Salad dressings; Mayonnaise; Ketchup
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/40—Foaming or whipping
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/77—Ovalbumin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/16—Vegetable proteins from soybean
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/04—Colour
    • A23V2200/042—Browning
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/12—Replacer
    • A23V2200/122—Egg replacer
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/14—Mouthfeel improving agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/21—Binding agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/22—Coating agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/222—Emulsifier
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/228—Gelling agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/23—Humectant
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/246—Whipping agent
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5428—Egg protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Definitions

  • Proteins are important dietary nutrients and food ingredients. They can serve as a fuel source or as sources of amino acids, including the essential amino acids that cannot be synthesized by the body.
  • the daily recommended intake of protein for healthy adults is 10% to 35% of a person’s total calorie needs, and currently the majority of protein intake for most humans is from animal-based sources.
  • proteins are used in a wide variety of foods and food ingredients. In many cases, these proteins are sourced from animals. With the world population growth and the coinciding growth in global food demand, there is a need to provide alternative sustainable, non animal-based sources of proteins as useful source of protein for daily diet, food ingredients and food products.
  • the ingredient composition for producing an egg-less food item may comprise a recombinant ovalbumin (rOVA), wherein the pH of the rOVA may be between about 3.5 and about 7.0; wherein the rOVA when present in the egg-less food item in an amount between about 2% and about 15% (w/w); and wherein the rOVA provides to the egg-less food item at least one egg white characteristic selected from gelling, foaming, whipping, fluffing, binding, springiness, aeration, coating, film forming, emulsification, browning, thickening, texturizing, humectant, clarification, and cohesiveness.
  • rOVA recombinant ovalbumin
  • the composition may be dried or may be a powder.
  • the composition may comprise at least 75% rOVA (w/w of total protein or w/w of total composition).
  • the powder composition may be a concentrate.
  • the powder composition may be an isolate.
  • the powder composition may be at least about 75%, at least about 80%, at least about 85%, or at least about 90% rOVA (w/w).
  • the powder composition is at least about 80%, at least about 85%, or at least about 90% rOVA (w/w).
  • the powder is a concentrate.
  • the powder composition is an isolate.
  • the composition may be a liquid.
  • the liquid composition may comprise at least 50% rOVA (w/w of total protein or w/w of composition). In some cases, the liquid the composition comprises at least about 60%, at least about 65%, at least about 75%, at least about 80%, at least about 85%, or at least about 90% rOVA (w/w).
  • the term w/w of total protein in the context of a % rOVA means that the rOVA comprises a defined percentage of the total protein in the composition.
  • a composition comprising at least 50% rOVA w/w of total protein would have at least half of the total protein being rOVA and the other half or so being another protein.
  • the total composition does not necessarily need to be at least 50% rOVA by weight, only the composition's protein content must be at least 50% rOVA.
  • the rOVA provides an equivalent or an improvement in the characteristic compared to native egg white in a similar food item.
  • the rOVA provides a foam capacity of at least 20%, 30%, 40%, or 50% greater than native egg white.
  • the rOVA provides a time to foaming that may be at least 20%, 30%, 40%, or 50% faster than native egg white.
  • the pH of the rOVA when solubilized is between about 3.5 and about 4.5.
  • the rOVA provides a hardness to the egg-less food composition that may be greater than native egg white.
  • the rOVA provides a chewiness to the egg-less food composition that may be greater than native egg white.
  • the rOVA provides a springiness comparable to native egg white.
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 1 or an amino acid sequence with at least 70% identity to SEQ ID NO: 2 or SEQ ID NO: 1.
  • the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich OVA, or a chicken OVA.
  • the amino acid sequence of the rOVA lacks an N-terminal methionine.
  • the rOVA further includes an EAEA amino acid sequence (SEQ ID NO: 75) at its N-terminus.
  • the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of a chicken OVA and the pH is between about 6.5 and 7.0 when solubilized. In some cases, the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of an ostrich OVA and the pH is less than about 6.0 and above about 3.7 when solubilized.
  • the pH when solubilized may be between about 6 and about 6.8. In some cases, the pH of the rOVA when solubilized may be less than about 6.1. In some cases, the rOVA may be present in the egg-less food item in an amount of less than about 8%. In some cases, the rOVA may be present in the egg-less food item in an amount of about 7% or less than 7%.
  • a baked food product may comprise: (i) a recombinant ovalbumin (rOVA), wherein the pH of the rOVA when solubilized may be between about 3.5 and about 7.0; (ii) at least one fat or oil; (iii) at least one grain starch; and (iv) at least one sweetener; wherein the rOVA provides the baked food product at least one egg white characteristic selected from binding, springiness, aeration, browning, texturizing, humectant, and cohesiveness, and the baked food product does not comprise any natural egg white proteins or a natural egg white.
  • rOVA recombinant ovalbumin
  • the rOVA may be present at about 2% to 15% in the product (w/w of total protein or w/w of total food product prior to baking). In some cases, the rOVA is present at about 2% to about 5% in the product (w/w).
  • the baked good may comprise a dairy component or a leavening agent, or a combination thereof.
  • the product may be a cake, a bread, a roll, a pastry, a cracker, a muffin, a scone, a biscuit, or a cookie.
  • the baked product may have a crumb structure equivalent to or better than a similar baked product made with a natural egg white or a natural whole egg.
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 1 or an amino acid sequence with at least 70% identity to SEQ ID NO: 2 or SEQ ID NO: 1.
  • the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich OVA, or a chicken OVA.
  • the percentage weight loss is lower in a baked product made with rOVA when compared to an equivalent baked product made with whole egg.
  • An emulsified product may comprise: (i) a recombinant ovalbumin (rOVA); (ii) at least one fat or oil; (iii) water; wherein the rOVA may be present in the product at about 2% to 15% (w/w).
  • the emulsified product may comprise an acidifying agent.
  • the product may be a salad dressing, a sauce, mayonnaise, sandwich spread or a gravy.
  • a recombinant ovalbumin comprising (i) a recombinant ovalbumin (rOVA), wherein the pH of the rOVA when solubilized may be between about 3.5 and about 7.0; (ii) at least one sweetener; and (iii) optionally, a consumable liquid; wherein the rOVA may be present in the food product at about 2% to about 15% (w/w) and wherein the rOVA provides foaming, whipping, fluffing or aeration to the food product.
  • rOVA recombinant ovalbumin
  • the rOVA may further provide gelation to the food product.
  • the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of a chicken OVA and the pH is between about 6.5 and 7.0 when solubilized.
  • the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of an ostrich OVA and the pH is less than about 6.0 and above about 3.7 when solubilized.
  • the food product may be a meringue, a whipped dessert, a whipped topping or a souffle.
  • the rOVA may provide a foam capacity to the food product of at least 20%, 30%, 40%, or 50% greater than native egg white.
  • the rOVA may provide a time to foaming to the food product that may be at least 20%, 30%, 40%, or 50% faster than native egg white.
  • the pH of the rOVA when solubilized is between about 3.5 and about 4.5.
  • the rOVA is present in the food product at about 5% to about 10% (w/w). In some cases, the rOVA is present in the food product at about 7% to about 8% (w/w). In some cases, the rOVA is present in the food product at about 4%, about 7%, or about 12% (w/w). In some cases, the pH of the rOVA when solubilized is about 6. In some cases, the rOVA is present in the food product at between about 9% and about 10% (w/w). In some cases, the pH of the rOVA when solubilized is about 7. In some cases, the product may be a beverage. In some cases, the beverage may be a consumable alcohol.
  • the rOVA provides foaming, whipping, fluffing or aeration to the consumable alcohol beverage.
  • the beverage is a coffee drink.
  • the rOVA provides foaming, whipping, fluffing or aeration to the coffee drink.
  • the coffee drink lacks a dairy component.
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 1 or an amino acid sequence with at least 70% identity to SEQ ID NO: 2 or SEQ ID NO: 1.
  • the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich OVA, or a chicken OVA.
  • the rOVA does not contaminate the food product with Salmonella.
  • the food product is a protein bar, an energy bar, a nutrition bar or a granola bar.
  • the food product comprises between about 4% and about 8% (w/w) rOVA.
  • the bar is baked or is unbaked.
  • a meat-analog food product may comprise: (i) a recombinant ovalbumin (rOVA); (ii) at least one fat or oil; and (iii) a plant-derived protein; wherein the rOVA may be present in the food product between about 2% and about 15% (w/w); and wherein the rOVA acts as a binding agent or a gelling agent, or a combination thereof.
  • the plant protein may be an extruded plant protein. In some cases, the plant protein may be a non-extruded plant protein.
  • the meat analog food product may be selected from a burger, patty, sausage, hot dog, sliced deli meat, jerky, bacon, nugget, a ground meat-like composition, and a formed meat-like composition.
  • the rOVA may provide a hardness to the food product that may be greater than native egg white.
  • the rOVA may provide a chewiness to the food product that may be greater than native egg white.
  • the rOVA may provide a springiness comparable to native egg white.
  • the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of a chicken OVA and the pH is between about 6.5 and 7.0 when solubilized. In some cases, the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of an ostrich OVA and the pH is less than about 6.0 and above about 3.7 when solubilized.
  • the rOVA is present in the food product at about 4%, at about 5%, or at about 6%
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ
  • the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich
  • An egg-white substitute may comprise: (i) a recombinant ovalbumin (rOVA); (ii) at least one fat or oil; and (iii) a polysaccharide or polysaccharide-containing ingredient; wherein the rOVA may be present in the composition at about 2% to 15% (ww); and wherein the composition may have one or more characteristics selected from hardness, adhesiveness, fracturability, cohesiveness, gumminess, and chewiness, and the one or more characteristics are equivalent to or improved as compared to natural egg white when the egg-white substitute may be cooked.
  • the egg-white substitute may further comprise a flavoring agent or a coloring agent, or a combination thereof.
  • the polysaccharide or polysaccharide-containing ingredient may be a starch.
  • the polysaccharide or polysaccharide-containing ingredient may be selected from gellan gum, sodium alginate, and psyllium or any combination thereof.
  • the rOVA may provide a hardness to the food product that may be greater than native egg white.
  • the rOVA may provide a chewiness to the food product that may be greater than native egg white. In some cases, the rOVA may provide a gumminess and/or springiness comparable to native egg white. In some cases, the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of a chicken OVA and the pH is between about 6.5 and 7.0 when solubilized. In some cases, the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of an ostrich OVA and the pH is less than about 6.0 and above about 3.7 when solubilized. In some cases, the rOVA is present in the food product between about
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 1 or an amino acid sequence with at least 70% identity to SEQ ID NO: 2 or SEQ ID NO: 1.
  • the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich OVA, or a chicken OVA.
  • a powdered ingredient composition may comprise a recombinant ovalbumin (rOVA), wherein the pH of the rOVA when solubilized may be between about 3.5 and about 7.0, wherein the rOVA may be at least 75% w/w of the composition, and wherein the rOVA may comprise one or more N-linked glycosylation sites having mannose linked to an N-acetyl glucosamine, and wherein the N-linked glycosylation sites lack galactose.
  • rOVA recombinant ovalbumin
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 1 or an amino acid sequence with at least 70% identity to SEQ ID NO: 2 or SEQ ID NO: 1.
  • the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich OVA, or a chicken OVA.
  • the amino acid sequence of the rOVA lacks an N-terminal methionine.
  • the rOVA further includes an EAEA amino acid sequence (SEQ ID NO: 75) at its N-terminus.
  • the composition comprises at least at least about 80%, at least about 85%, or at least about 90% rOVA (w/w).
  • a liquid composition may comprise a recombinant ovalbumin (rOVA) and the composition may comprise at least 50% rOVA (w/w of total protein or w/w of total composition). In some cases, the composition may comprise at least about 60%, at least about 65%, at least about 75%, at least about 80%, at least about 85%, or at least about 90% rOVA (w/w).
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 1 or an amino acid sequence with at least 70% identity to SEQ ID NO: 2 or SEQ ID NO: 1. In some cases, the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich OVA, or a chicken OVA.
  • the amino acid sequence of the rOVA lacks an N-terminal methionine.
  • the rOVA further includes an EAEA amino acid sequence (SEQ ID NO: 75) at its N- terminus.
  • the pH of the solubilized rOVA may be between about 3.5 and about 7.0. In some cases, the pH of the solubilized rOVA may be between about 6 and about 6.8. In some cases, the pH of the solubilized rOVA may be less than about 6.1.
  • the rOVA may provide to an egg-less food item at least one egg white characteristic selected from gelling, foaming, whipping, fluffing, binding, springiness, aeration, coating, film forming, emulsification, browning, thickening, texturizing, humectant, clarification, and cohesiveness.
  • the rOVA may provide an equivalent or an improvement in the characteristic compared to native egg white in a similar egg-less food item.
  • the rOVA may provide to the egg-less food item a foam capacity of at least 20%, 30%, 40%, or 50% greater than native egg white.
  • the rOVA may provide to the egg-less food item a time to foaming that may be at least 20%, 30%, 40%, or 50% faster than native egg white. In some cases, the rOVA may provide to the egg-less food item a hardness that may be greater than native egg white. In some cases, the pH of the rOVA when solubilized is between about 3.5 and about 4.5. In some cases, the rOVA is present in the egg-less food item at about 5% to about 10% (w/w). In some cases, the rOVA is present in the egg-less food item at about 7% to about 8% (w/w).
  • the rOVA is present the egg-less food item at about 4%, about 7%, or about 12% (w/w).
  • the pH of the rOVA when solubilized is about 6.
  • the rOVA may provide to the egg-less food item a chewiness that may be greater than native egg white.
  • the rOVA may provide to the egg-less food item a springiness comparable to native egg white.
  • the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of a chicken OVA and the pH is between about 6.5 and 7.0 when solubilized. In some cases, the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of an ostrich OVA and the pH is less than about 6.0 and above about 3.7 when solubilized. In some cases, the rOVA does not contaminate the egg-less food item with Salmonella.
  • compositions comprising a recombinant ovalbumin (rOVA), wherein the composition may comprise at least 50% rOVA (w/w of total protein or w/w of total composition).
  • the composition may comprise at least about 60%, at least about 65%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, or at least about 95% rOVA (w/w).
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 1 or an amino acid sequence with at least 70% identity to SEQ ID NO: 2 or SEQ ID NO: 1.
  • the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich OVA, or a chicken OVA.
  • the amino acid sequence of the rOVA lacks an N-terminal methionine.
  • the rOVA further includes an EAEA amino acid sequence (SEQ ID NO: 75) at its N-terminus.
  • the rOVA may provide to an egg-less food item at least one egg white characteristic selected from gelling, foaming, whipping, fluffing, binding, springiness, aeration, coating, film forming, emulsification, browning, thickening, texturizing, humectant, clarification, and cohesiveness.
  • the rOVA may provide an equivalent or an improvement in the characteristic compared to native egg white in a similar egg-less food item.
  • the rOVA may provide to the egg-less food item a foam capacity of at least
  • the rOVA may provide to the egg-less food item a time to foaming that may be at least 20%, 30%, 40%, or 50% faster than native egg white.
  • the pH of the rOVA when solubilized is between about 3.5 and about 4.5.
  • the rOVA is present in the egg-less food at about 4%, about 7%, or about
  • the pH of the rOVA when solubilized is about 6.
  • the rOVA may provide to the egg-less food item a hardness that may be greater than native egg white. In some cases, the rOVA may provide to the egg-less food item a chewiness that may be greater than native egg white. In some cases, the rOVA may provide to the egg-less food item a springiness comparable to native egg white. In some cases, the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of a chicken OVA and the pH is between about 6.5 and 7.0 when solubilized. In some cases, the rOVA provides improved gelation when the rOVA comprises an amino acid sequence of an ostrich OVA and the pH is less than about 6.0 and above about 3.7 when solubilized.
  • a method of making a food product may comprise: (i) providing a recombinant ovalbumin (rOVA) at a pH when solubilized of between about 3.5 and about 7.0; (ii) combining the rOVA in an amount between 2% and 15% (w/w) with one or more consumable ingredients to form a food product, wherein the rOVA may provide at least one egg white characteristic to the food product selected from gelling, foaming, whipping, fluffing, binding, springiness, aeration, coating, film forming, emulsification, browning, thickening, texturizing, humectant, clarification and cohesiveness.
  • rOVA recombinant ovalbumin
  • a method of producing an ingredient composition may comprise: (i) expressing a recombinant ovalbumin (rOVA) in a microbial cell, wherein the rOVA may be secreted by the microbial cell into a liquid media; (ii) harvesting the liquid media containing secreted rOVA; (iii) performing a separation step at a pH of about 3.5; (iv) solubilizing the rOVA at a pH of about 12; (v) adjusting the final pH of the rOVA to between about 3.5 and about 7.0 to generate the ingredient composition.
  • rOVA recombinant ovalbumin
  • the separation step may comprise ion exchange chromatography or ammonium sulfate precipitation.
  • the ion exchange chromatography may be cation exchange chromatography or anion exchange chromatography, or a combination thereof.
  • the method further may comprise a filtration step following the solubilizing step.
  • the microbial cell may be a fungal cell.
  • the fungal cell may be a Pichia sp.
  • the microbial cell expresses a recombinant helper factor; wherein the helper factor enhances the level of expression or accumulation of rOVA.
  • the rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ
  • the rOVA may comprise an amino acid sequence of a duck OVA, an ostrich
  • the amino acid sequence of the secreted rOVA lacks an
  • the secreted rOVA further includes an EAEA amino acid sequence (SEQ ID NO: 75) at its N-terminus.
  • an egg-less food product may comprise a recombinant ovalbumin (rOVA) in an amount of between about 15% and about 25% (w/w of total protein or w/w of food product). In some cases, the egg-less food product may comprise the rOVA) in an amount of up to about 23% (w/w).
  • rOVA recombinant ovalbumin
  • recombinant ovalbumin may be used as an ingredient in making a baked good.
  • rOVA may be used as an ingredient in making an egg-less food product.
  • rOVA may be used as an ingredient in making a meat-analog food product.
  • rOVA may be used as an ingredient in making an egg-white substitute.
  • rOVA may be used as a substitute egg-wash for a baked product; wherein the substitute egg-wash may provide film formation equivalent to or better than an egg-wash may comprise a natural egg white or a natural whole egg.
  • rOVA may comprise an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 1 or an amino acid sequence with at least 70% identity to SEQ ID NO: 2 or SEQ ID NO: 1.
  • rOVA may comprise an amino acid sequence of a duck OVA, an ostrich OVA, or a chicken OVA. In some cases, the rOVA is present in the egg-wash in an amount between 8% and 9% (w/w).
  • a large-scale production of rOVA may comprise an at least 1 -liter liquid culture of microbial cells expressing the rOVA.
  • the large-scale production may comprise an at least 10-liter liquid culture of microbial cells expressing the rOVA.
  • the large-scale production may comprise an at least 100-liter liquid culture of microbial cells expressing the rOVA.
  • the large-scale production may comprise an at least 1000- liter liquid culture of microbial cells expressing the rOVA.
  • the large-scale production comprises an at least 10,000-liter liquid culture of microbial cells expressing the rOVA. In some cases, the large-scale production comprises an at least 100,000-liter liquid culture of microbial cells expressing the rOVA. In some cases, the large-scale production comprises about a 200,000-liter liquid culture of microbial cells expressing the rOVA.
  • an ingredient composition for producing an egg-less food item comprising a recombinant ovalbumin.
  • the recombinant ovalbumin may provide at least one egg white characteristic selected from the group consisting of gelling, foaming, whipping, fluffing, binding, springiness, aeration, coating, film forming, emulsification, browning, thickening, texturizing, humectant, clarification and cohesiveness.
  • the egg white characteristic provided by the recombinant ovalbumin may be substantially the same or better than the same characteristic provided by a native egg white.
  • the composition may not contain any native egg white protein.
  • the composition may not contain any animal products.
  • the composition may not contain any protein extracted from an egg.
  • the color of the composition may be improved in whiteness or colorlessness as compared to a native egg white.
  • the recombinant ovalbumin may comprise a polypeptide sequence derived from the group consisting of chicken, goose, quail, ostrich, and duck.
  • the recombinant ovalbumin may be sensory neutral with regard to taste, smell, mouthfeel or any combination thereof.
  • the recombinant ovalbumin may provide the features of foaming and coagulation to the composition.
  • baked products comprising the ingredient composition provided herein.
  • the recombinant ovalbumin may provide structure, texture or both structure and texture to the baked product.
  • the recombinant ovalbumin may provide a protein fortification to the baked product.
  • the recombinant ovalbumin may be at a concentration of between about 1% and about 20% (weight ovalbumin/weight product) in a baked product.
  • the recombinant ovalbumin may be at a concentration of between about 0.1% and about 5% (weight ovalbumin/weight product) in a baked product.
  • the recombinant ovalbumin may be compatible with gluten formation.
  • the baked product may be selected from the group consisting of cake, cookie, bagel, biscuit, bread, muffin, cupcake, scone, pancake, macaroon, meringue, choux pastry and souffle.
  • the cake made using such an ingredient may be pound cake, sponge cake, yellow cake, or angel food cake.
  • the composition may further comprise one or more components selected from the group consisting of a sweetening agent, a gum, a hydrocolloid, a starch, a fiber, a plant protein, algal protein, a coloring agent and a flavoring extract.
  • the composition may provide one or more characteristics suitable for an egg-like dish, and wherein the characteristic may be selected from the group consisting of foaming, coagulation, binding, structure, texture, film-formation, nutritional profile, cholesterol free and protein fortification.
  • egg-like dishes comprising the ingredient composition described herein.
  • the egg-like dish may be selected from the group consisting of scramble, omelet, patty, souffle, quiche and frittata.
  • the egg-like dish may be vegan, vegetarian, halal or kosher.
  • the composition may provide one or more characteristics suitable for a processed meat product or meat-like product, and wherein the characteristic may be selected from the group consisting of high protein content, binding, and sensory neutrality.
  • meat-like products comprising the ingredient compositions provided herein.
  • the meat-like product may be selected from the group consisting of a burger, patty, sausage, hot dog, sliced deli meat, jerky, bacon, nugget and ground meat-like mixture or formed meat or meat-like composition.
  • Ovalbumin may be present in an amount between about 0.1% and
  • the recombinant ovalbumin may provide the characteristic of binding suitable for adhesion of a food coating.
  • a food coating may comprise the ingredients described herein.
  • the food coating may be a batter or a breading.
  • the recombinant ovalbumin may further provide the characteristic of crunchy texture to the food coating when cooked, baked or fried.
  • the recombinant ovalbumin may provide the characteristic suitable for a confectionary selected from the group consisting of odor neutrality, flavor, mouthfeel, texture, nutritional value and protein fortification.
  • a confectionary product may comprise the ingredient compositions described herein.
  • the confectionary may not contain egg or egg white.
  • the confectionary may not contain any proteins extracted from egg or egg white.
  • the recombinant ovalbumin may provide a firm or chewy texture to the confectionary.
  • the recombinant ovalbumin may be present in an amount between about 0.1% and 15% (weight ovalbumin/weight confectionary).
  • the confectionary may be a gummy, a taffy or a nougat.
  • the recombinant ovalbumin may provide a characteristic suitable for a dairy-like beverage selected from the group consisting of odor neutrality, flavor, mouthfeel, foaming, frothiness, texture, and nutritional value.
  • a dairy-like beverage may comprise the ingredient compositions described herein.
  • the dairy-like beverage may not contain egg or egg white.
  • the beverage may be selected from the group consisting of smoothie, milkshake, “egg-nog”, and coffee beverage.
  • the recombinant ovalbumin may be present in an amount between about 0.1% and 20% (weight ovalbumin/volume beverage).
  • Recombinant ovalbumin may provide a characteristic suitable for a dessert product selected from the group consisting of creamy texture, low fat content, odor neutrality, flavor, mouthfeel, texture, binding, and nutritional value.
  • a dessert product may comprise the ingredient compositions described herein.
  • the dessert product may be selected from the group consisting of a mousse, a cheesecake, a custard, a pudding, a popsicle, a frozen dessert, and an ice cream.
  • the dessert product may be vegan, vegetarian or dairy-free.
  • the recombinant ovalbumin may be present in an amount between about 0.1% and 10% (weight ovalbumin/weight dessert product).
  • the recombinant ovalbumin may provide a characteristic suitable for a sauce or dressing selected from the group consisting of binding, emulsifying, odor neutrality, and mouthfeel.
  • a sauce or dressing may comprise the ingredient compositions described herein.
  • the sauce or dressing may be selected from the group consisting of salad dressing, mayonnaise, commercial mayonnaise substitutes, alfredo sauce, and hollandaise sauce.
  • the sauce or dressing may not contain egg, egg white, or any protein extracted from egg.
  • the recombinant ovalbumin may provide a characteristic suitable for a snack food selected from the group consisting of binding, protein supplementation, flavor neutrality, odor neutrality, and mouth feel.
  • a snack food may comprise the ingredient compositions described herein.
  • the snack food may be a protein bar, a nutrition bar or a granola bar.
  • the ingredient composition may further comprise one or more additional components selected from the group consisting of a sweetener, a gum, a plant protein, algal protein, a flavoring, a colorant, a thickener, an acidulant and an emulsifier.
  • the egg-white replacer may comprise providing a recombinant ovalbumin; mixing the recombinant ovalbumin with at least one additional component to form the egg white replacer.
  • the recombinant ovalbumin may provide at least one egg white characteristic selected from the group consisting of gelling, foaming, whipping, fluffing, binding, springiness, aeration, creaminess and cohesiveness to the egg white replacer.
  • the egg white replacer may not contain any egg, egg white, protein extracted or isolated from egg.
  • the at least one egg white characteristic may be the same or better than a native egg provided in the same amount or concentration (weight/volume).
  • the method may further comprise producing the recombinant ovalbumin in a heterologous host cell, wherein the host cell may be E.coli, yeast, filamentous fungus, or Trichoderma.
  • the yeast or filamentous fungus may be selected from the group consisting of a Saccharomyces species and a Pichia species.
  • the recombinant ovalbumin may be secreted from the host cell.
  • the recombinant ovalbumin may be glycosylated by the host cell and wherein the glycosylation of the ovalbumin may be not identical to ovalbumin isolated from chicken egg.
  • the method may further comprise treating the secreted ovalbumin with a deglycosylation enzyme.
  • the deglycosylation enzyme may be expressed by the host cell.
  • the host may comprise a nucleic acid sequence encoding the recombinant ovalbumin, and the recombinant ovalbumin has an amino acid sequence of an ovalbumin from an avian species.
  • the host may comprise a nucleic acid sequence encoding the recombinant ovalbumin, and the recombinant ovalbumin has an amino acid sequence of an ovalbumin that has at least 95% sequence identity with an ovalbumin from an avian species.
  • the avian species may be chicken, duck, goose, ostrich, or quail.
  • the ovalbumin from the avian species may be selected from the group consisting of SEQ
  • a recombinant protein composition for use as an egg-white replacer.
  • the composition can comprise a recombinant ovalbumin and at least one additional component.
  • the recombinant ovalbumin may provide at least one egg white characteristic selected from the group consisting of gelling, foaming, whipping, fluffing, binding, springiness, aeration, creaminess and cohesiveness to the composition.
  • the composition may not contain any egg, egg white, protein extracted or isolated from egg.
  • the at least one egg white characteristic may be the same or better than a native egg compared at the same amount or concentration (weight/volume).
  • the recombinant ovalbumin may have an amino acid sequence of an ovalbumin from an avian species.
  • the recombinant ovalbumin may have an amino acid sequence of an ovalbumin that has at least 95% sequence identity with an ovalbumin from an avian species.
  • the avian species may be chicken, duck, goose, ostrich, or quail.
  • the ovalbumin from the avian species may be selected from the group consisting of SEQ ID NO. 1-74.
  • An animal nutrition composition may comprise a recombinant ovalbumin (rOVA).
  • the rOVA may be in a form selected from whole cell extract, fractionated cell extract and isolated protein.
  • the composition may be comprised within a pet food, an animal feed, a chewy treat, bone broth, smoothie or other liquid for animal nutrition and a solid nutritional supplement suitable for animal consumption.
  • any composition, food product, ingredient, use, or method disclosed herein is applicable to any herein-disclosed composition, food product, ingredient, use, or method.
  • any aspect or embodiment described herein can be combined with any other aspect or embodiment as disclosed herein.
  • FIGs. 1A-B illustrate glycosylation patterns of native OVA and rOVA produced in P. pastoris respectively.
  • FIG. 2 illustrates pound cakes and their cross-sections made using rOVA compared to cakes made using eggs.
  • FIG. 3 illustrates meringues made using rOVA compared to meringues made using eggs.
  • FIG. 4 illustrates heat coagulation and foaming properties of whole egg, egg white and native OVA solutions.
  • FIG. 5 illustrates heat coagulation and foaming properties of egg white and native OVA compared to rOVA.
  • FIG. 6A illustrates gel electrophoresis migration of glycosylated native and recombinant OVA. Also shown are deglycosylated recombinant OVA treated with EndoH and PNGaseF enzymes.
  • FIG. 6B illustrates a chromatogram depicting glycosylation patterns of rOVA produced in P. pastoris.
  • FIG. 7 illustrates gelation results before and after foaming of various OVA samples compared to egg white.
  • FIG. 8 illustrates film formation using nOVA, rOVA, whole egg wash and a commercial egg-white substitute.
  • FIGs. 9A-B illustrates emulsification results of nOVA, rOVA and egg white protein at acidic and neutral pH.
  • FIG. 10 illustrates foaming of rOVA and control samples in an alcohol-based drink.
  • FIG. 11 illustrates egg patties made using nOVA, rOVA and egg white proteins.
  • FIG. 12 illustrates meringues made using rOVA samples and egg white proteins.
  • FIG. 13 illustrates protein bars made with egg white proteins (EWP), nOVA and rOVA at different protein inclusion levels.
  • EWP egg white proteins
  • compositions and methods of making compositions for non-animal- based sources of proteins which provide nutritional as well as functional properties to food ingredients and consumable products for ingestion by an animal, including a human, such as for daily diet, ingredients for human food and treats and for human and animal nutrition.
  • compositions and methods provided herein contain fermentation-derived ovalbumin, produced through recombinant technology, i.e., a recombinant ovalbumin (rOVA).
  • rOVA recombinant ovalbumin
  • the compositions and methods for making compositions comprising rOVA can increase the protein content of a consumable or food ingredient, and also provide functional features for use in the preparation of food ingredients and consumable food products for animal and human ingestion.
  • the rOVA provides one or more functional characteristics such as of gelling, foaming, whipping, fluffing, binding, springiness, aeration, coating, film forming, emulsification, browning, thickening, texturizing, humectant, clarification, and cohesiveness.
  • the rOVA with such feature(s) can be a food ingredient that provides for production of an egg-less or animal-free food ingredient or food product.
  • native in the context of native egg white, native egg protein, native ovalbumin and native egg, refers to the egg white, egg protein, ovalbumin or whole egg, respectively, produced by an animal or collected from an animal, in particular an egg-laying animal such as a bird.
  • the rOVA and compositions containing rOVA can be used in food ingredients and food products, such that the ingredient or product does not contain any native egg white, native egg protein, native ovalbumin or native egg. In some cases, the ingredients or food products made using rOVA do not include any egg-white proteins other than rOVA.
  • the rOVA and compositions containing rOVA can be used in food ingredients and food products, such that the ingredient or product does not contain any animal products.
  • the rOVA can (alone or with other ingredients) substitute for the use of whole egg or egg white in the production of a food product.
  • the feature(s) provided by the rOVA is substantially the same or better than the same characteristic provided by a native egg white or native egg.
  • the rOVA and compositions containing rOVA can have gelling, foaming, whipping, fluffing, binding, springiness, aeration, coating, film forming, emulsification, browning, thickening, texturizing, preserving moisture (humectant), clarification, and cohesiveness, improved color, such as a whiter color, as compared to native egg white or native whole egg and compositions made with native egg white.
  • Food ingredients and food products disclosed herein include compositions that comprise, consists essentially of, or consist of rOVA, where rOVA provides at least one functional feature to the composition, food ingredient, or food product.
  • at least one functional feature provided by the rOVA is comparable or substantially similar to a native egg or egg white or native OVA (nOVA). For instance, it may provide any one of gelling, foaming, whipping, fluffing, binding, springiness, aeration, coating, film forming, emulsification, browning, thickening, texturizing, preserving moisture (humectant), clarification, and cohesiveness comparable to a whole egg, egg-white or nOVA composition.
  • the at least one functional feature is provided by or provided substantially by the inclusion of rOVA in the food ingredient or food product, for example, in the absence of any other whole egg proteins or egg white proteins.
  • compositions can include rOVA in an amount between 0.1% and 25% on a weight/weight (w/w) or weight/volume (w/v) basis. rOVA may be present at or at least at 0.1%,
  • concentrations can be based on the dry weight of the composition. Additionally, or alternatively, the concentration of rOVA in such compositions is at most 30%, 20%, 15%, 10%, 5%, 4%, 3%, 2% or 1% on a w/w or w/v basis.
  • the rOVA in the food ingredient or food product can be at a concentration range of 0.1%-20%, 1% - 20%, 0.1%-10%, 1% - 10%, 0.1% - 5%, 1% - 5%, 2-10%, 4-8%, 4-10%,
  • rOVA provides at least one feature of whole egg or egg-whites to a consumable food composition.
  • rOVA is added to a consumable food composition to increase the protein content, such as for added nutrition.
  • rOVA is present in the consumable food composition between about 1% and about 40% on a weight per total weight (w/w) and/or weight per total volume (w/v) of composition basis.
  • rOVA is present at 30g and the rOVA is thus at a 30% concentration (w/v) or for example, in a composition of 100 g, rOVA is present at 30g and the rOVA is thus at a 30% concentration (w/w) .
  • the concentration of rOVA is or is about 0.5%, 1%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39% or 40% on a w/w and/or w/v of composition basis.
  • the rOVA is present at a concentration of or of about 0.5-1%, 1-5%, 2-8%, 4-8%, 2-12%, 4-12%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30% or rOVA is present concentration greater than 1%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39% or 40% w/w and/or w/v.
  • a consumable product can include one or more other proteins, such as a non-OVA protein or a non-recombinant protein.
  • the rOVA can increase amount of protein content in a consumable product, and/or provide one or more egg-white like features.
  • the consumable composition can include a whey protein, a pea protein, a soy protein, an almond protein, an oat protein, a flax seed protein, a vegetable protein, or an egg-white protein.
  • the consumable protein may include an extruded plant protein or a non-extruded plant protein.
  • the one or more other proteins can comprise OVA having an amino acid sequence naturally found in a bird or a reptile.
  • compositions and methods for making compositions have an egg-white like property and increase the protein content in the composition. In some embodiments, the compositions and methods for making compositions with an egg-white like property increase the protein content, while not adversely affecting the stability, or one or more sensory qualities of the composition.
  • the consumable food compositions and methods for making consumable food compositions comprise rOVA and the addition of rOVA generates an egg-white like composition.
  • the consumable food composition may be a finished product or an ingredient for making a finished product, e.g., a liquid or a powdered rOVA composition.
  • rOVA protein may be used on its own or in combination with other components to form a composition.
  • rOVA is used as an ingredient to form a composition and the rOVA ingredient (or rOVA starting composition to be added) may contain about or at least about 10%, 20%, 30%, 40%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% rOVA by weight per total weight (w/w) and/or weight per total volume (w/v).
  • a composition described herein may contain up to about 10%, 20%, 30%, 40%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% rOVA by w/w or w/v.
  • about or at least about 10%, 20%, 30%, 40%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% of the protein in a composition is rOVA by weight per total weight (w/w) and/or weight per total volume (w/v).
  • up to or about 10%, 20%, 30%, 40%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% of the protein in a composition is rOVA by w/w or w/v.
  • a composition described herein contains total protein at a concentration of about or at least 5, 6, 7, 8, 9, 10, 11, 12, 13, 13.2, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, or 75 g total protein per 100 mL liquid (e.g., water). In some cases, a composition described herein contains total protein at a concentration of about or at least 5, 6, 7, 8, 9, 10, 11, 12, 13, 13.2, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100 g total protein per 100 g composition (e.g., powder).
  • a composition described herein contains rOVA at a concentration of about or at least 5, 6, 7, 8, 9, 10, 11, 12, 13, 13.2, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, or 75 g per 100 mL liquid (e.g., water).
  • a composition described herein contains rOVA at a concentration of about or at least 5, 6, 7, 8, 9, 10, 11, 12, 13, 13.2, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70,
  • composition e.g., powder
  • a composition described herein contains total protein at a concentration of about or at least 0.1, 0.2, 0.3, 0.5, 0.7, 1.0, 1.2, 1.5, 1.7, 2.0, 2.2, 2.5, 2.7, 3.0, 3.2, 3.5, 3.7, 4.0, 4.2, 4.5, 4.7 or 5g total protein per 100 mL liquid (e.g., water).
  • liquid e.g., water
  • a composition described herein contains total protein at a concentration of about or at least 0.1, 0.2, 0.3, 0.5, 0.7, 1.0, 1.2, 1.5, 1.7, 2.0, 2.2, 2.5, 2.7, 3.0, 3.2, 3.5, 3.7, 4.0, 4.2, 4.5, 4.7 or 5g total protein per 100 g composition (e.g., powder).
  • a composition described herein contains rOVA at a concentration of about or at least 0.1, 0.2, 0.3, 0.5, 0.7, 1.0, 1.2, 1.5, 1.7, 2.0, 2.2, 2.5, 2.7, 3.0, 3.2, 3.5, 3.7, 4.0,
  • a composition described herein contains rOVA at a concentration of about or at least 0.1, 0.2, 0.3, 0.5, 0.7, 1.0, 1.2, 1.5, 1.7, 2.0,
  • composition e.g., powder.
  • the rOVA consumable composition is a liquid composition.
  • the concentration of rOVA in the liquid composition may be between 0.1% to 90%.
  • the concentration of rOVA in the liquid composition may be at least 0.1%.
  • the concentration of rOVA in the liquid composition may be at most 90%.
  • the concentration of rOVA in the liquid composition may be from 0.1% to 1%, 0.1% to 5%, 0.1% to 10%, 0.1% to 15%, 0.1% to 20%, 0.1% to 25%, 0.1% to 30%, 0.1% to 35%, 0.1% to 40%, 1% to 5%, 1% to 10%, 1% to 15%, 1% to 20%, 1% to 25%, 1% to 30%, 1% to 35%, 1% to 40%, 5% to 10%, 5% to 15%, 5% to 20%, 5% to 25%, 5% to 30%, 5% to 35%, 5% to 40%, 10% to 15%, 10% to 20%, 10% to 25%, 10% to 30%,
  • the concentration of rOVA in the liquid composition may be about 0.1%, 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, or 95% w/v.
  • the concentration of rOVA in the liquid composition may be at least 0.1%, 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, or 95% w/v.
  • the concentration of rOVA in the liquid composition may be at most 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35% 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, or 95% w/v.
  • rOVA is the sole protein in the liquid composition.
  • a liquid composition comprises proteins other than rOVA.
  • the rOVA consumable composition is a solid composition. In such cases, the concentration of rOVA in the solid composition may be between 0.1% to 70%. The concentration of rOVA in the solid composition may be at least 0.1%. The concentration of rOVA in the solid composition may be at most 70%.
  • the concentration of rOVA in the solid composition may be 0.1% to 1%, 0.1% to 10%, 0.1% to 20%, 0.1% to 30%, 0.1% to 40%, 0.1% to 50%, 0.1% to 60%, 0.1% to 70%, 1% to 10%, 1% to 20%, 1% to 30%, 1% to 40%, 1% to 50%, 1% to 60%,
  • 1% to 70% 10% to 20%, 10% to 30%, 10% to 40%, 10% to 50%, 10% to 60%, 10% to 70%, 20% to 30%, 20% to 40%, 20% to 50%, 20% to 60%, 20% to 70%, 30% to 40%, 30% to 50%, 30% to
  • the concentration of rOVA in the solid composition may be 0.1%, 1%, 10%, 20%, 30%, 40%, 50%, 60%, or 70% w/w or w/v.
  • the concentration of rOVA in the solid composition may be at least 0.1%, 1%, 10%, 20%,
  • the concentration of rOVA in the solid composition may be at most 1%, 10%, 20%, 30%, 40%, 50%, 60%, or 70% w/w or w/v.
  • the rOVA consumable composition is a powdered composition.
  • the concentration of rOVA in the powder composition may be between 15% to 99% weight per total weight (w/w) and/or weight per total volume (w/v).
  • the concentration of rOVA in the powder composition may be at least 15% w/w or w/v.
  • the concentration of rOVA in the powder composition may be at most 99% w/w or w/v.
  • the concentration of rOVA in the powder composition may be 15% to 30%, 15% to 45%, 15% to 60%, 15% to 75%, 15% to 80%, 15% to 85%, 15% to 90%, 15% to 95%, 15% to 99%, 30% to 45%, 30% to 60%, 30% to
  • the concentration of rOVA in the powder composition may be about 15%, 30%, 45%, 60%, 75%, 80%, 85%, 90%, 95%, or 99% w/w or w/v.
  • the concentration of rOVA in the powder composition may be at least 15%, 30%, 45%, 60%, 75%, 80%, 85%, 90% or 95% w/w or w/v.
  • the concentration of rOVA in the powder composition may be at most 30%, 45%, 60%, 75%, 80%, 85%, 90%, 95%, or 99% w/w or w/v.
  • rOVA is the sole protein in the powder composition.
  • a powder composition comprises proteins other than rOVA.
  • a powder composition may be a concentrate which comprises at least 70% rOVA w/w. In some cases, a powder composition may be a concentrate which comprises at least 80% rOVA w/w. In some cases, a powder composition may be an isolate which comprises at least 90% rOVA w/w. In some cases, a powder composition may be an isolate which comprises at least 95% rOVA w/w.
  • the rOVA consumable composition is a concentrated liquid composition. In such cases, the concentration of rOVA in the concentrated liquid composition may be between 10% to 60% weight per total weight (w/w) and/or weight per total volume (w/v).
  • the concentration of rOVA in the concentrated liquid may be at least 10% w/w or w/v.
  • the concentration of rOVA in the concentrated liquid may be at most 60% w/w or w/v.
  • the concentration of rOVA in the concentrated liquid may be 10% to 20%, 10% to 30%, 10% to 40%,
  • the concentration of rOVA in the concentrated liquid may be about 10%, 20%, 30%, 40%, 50%, or 60% w/w or w/v.
  • the concentration of rOVA in the concentrated liquid may be at least 10%, 20%, 30%, 40% or
  • the concentration of rOVA in the concentrated liquid may be at most 20%, 30%,
  • the liquid may include any consumable solvent, e.g., water, dairy, oil, or other cooking base.
  • the rOVA consumable composition is a prepared food for example, as a baked good, a salad dressing, an egg-like dish (such as an egg-patty or scramble), a dessert or dairy-like product or a meat-analog (such as a vegan meat patty, sausage or hot dog).
  • Such compositions can include rOVA in an amount between 0.1% and 20% on a weight/weight (w/w) or weight/volume (w/v) basis.
  • rOVA may be present at or at least at 0.1%, 0.2%, 0.25%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, or 20% on a weight/weight (w/w) or weight/volume (w/v) basis. Additionally, or alternatively, the concentration of rOVA in such compositions is at most 30%, 20%, 15%, 10%, 5%, 4%, 3%, 2% or 1% on a w/w or w/v basis.
  • the rOVA in the food ingredient or food product can be at a concentration range of 0.1%-20%, 1% - 20%, 0.1%-10%, 1% - 10%, 0.1% - 5%, 1% - 5%, 0.1% - 2%, 1% - 2% or 0.1-1%.
  • the rOVA containing compositions herein can provide one or more functional features to food ingredients and food products.
  • the rOVA provides a nutritional feature such as protein content, protein fortification and amino acid content to a food ingredient or food product.
  • the nutritional feature provided by rOVA in the composition may be comparable or substantially similar to an egg, egg white or native OVA (nOVA).
  • the nutritional feature provided by rOVA in the composition may be better than that provided by a native whole egg or native egg white.
  • rOVA provides the one or more functional features of egg-white in absence of any other egg-white proteins.
  • rOVA compositions disclosed herein can provide foaming and foam capacity to a composition.
  • rOVA can be used for forming a foam to use in baked products, such as cakes, for meringues and other foods where rOVA can replace egg white to provide foam capacity.
  • rOVA provides foaming and foam capacity of egg-white in absence of any other egg-white proteins.
  • a composition comprising rOVA may have a foam height greater than a foam height of an egg white or a composition comprising nOVA.
  • a composition comprising rOVA may have a foam height of about or at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 160%, 170%, 180%, 190%, 200%, 210%, 220%, 230%, 240%, 250%, 260%, 270%, 280%, 290%, 300%, 350%, 400%, 450%, or 500% relative to an egg white, nOVA compositions or a substitute egg white.
  • a composition comprising rOVA may have a foam height of up to 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 160%, 170%, 180%, 190%, 200%, 210%, 220%, 230%, 240%, 250%, 260%, 270%, 280%, 290%, 300%, 350%, 400%, 450%, or 500% relative to an egg white, nOVA compositions or a substitute egg white.
  • Substitute egg whites may include products such as aquafaba, chia seeds, flax seeds, starches; apple sauce, banana puree; condensed milk, etc. which are commonly used as egg white substitutes.
  • a composition comprising rOVA may have a foam stability greater than a foam stability of an egg white, nOVA compositions or a substitute egg white.
  • a composition comprising rOVA may have a foam stability of about or at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 160%, 170%, 180%, 190%, 200%, 210%, 220%, 230%, 240%, 250%, 260%, 270%, 280%, 290%, 300%, 350%, 400%, 450%, or 500% relative to an egg white or a substitute egg white.
  • a composition comprising rOVA may have a foam stability of up to 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 160%, 170%, 180%, 190%, 200%, 210%, 220%, 230%, 240%, 250%, 260%, 270%, 280%, 290%, 300%, 350%, 400%, 450%, or 500% relative to an egg white.
  • Foam stability may be calculated by measuring drainage of a foamed solution. The drainage may be measured in 10-minute increments for 30 minutes to gather data for foam stability. The drained volume after 30 minutes may be compared to the initial liquid volume (5mL) for instance, foam Stability (%): (Initial volume - drained volume) / initial volume* 100.
  • a composition comprising rOVA may have a foam capacity greater than a foam capacity of an egg white, nOVA compositions or a substitute egg white.
  • a composition comprising rOVA may have a foam capacity of about or at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 160%, 170%, 180%, 190%, 200%, 210%, 220%, 230%, 240%, 250%, 260%, 270%, 280%, 290%, 300%, 350%, 400%, 450%, or 500% relative to an egg white, nOVA or a substitute egg white.
  • a composition comprising rOVA may have a foam capacity of up to 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 105%, 110%, 115%, 120%, 125%, 130%, 135%, 140%, 145%, 150%, 160%, 170%, 180%, 190%, 200%, 210%, 220%, 230%, 240%, 250%, 260%, 270%, 280%, 290%, 300%, 350%, 400%, 450%, or 500% relative to an egg white, nOVA compositions or a substitute egg white.
  • Foam capacity may be determined by measuring the initial volume of foam following the whipping and compare against the initial volume of 5mL.
  • Foam Capacity (%) (volume of foam / initial volume)* 100.
  • a liquid composition may foam faster than a composition comprising egg whites, nOVA or a substitute egg white.
  • an rOVA composition foams at least 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, faster than an egg white, nOVA or substitute egg-white composition.
  • an rOVA composition foams up to 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100% faster than an egg white, nOVA or substitute egg- white composition.
  • a composition comprising rOVA may have a gel strength greater than a gel strength of an egg white, nOVA composition or a egg white substitutes.
  • the rOVA composition may have a gel strength within the range from 100 g to 1500 g, from 500 g to 1500 g, or from 700 g to 1500 g.
  • an rOVA composition has a gel strength of about or at least 10, 50, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1050, 1100, 1150, 1200, 1250, 1300, 1350, 1400, 1450, or 1500 g.
  • an rOVA composition has a gel strength of up to 10, 50, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1050, 1100, 1150, 1200, 1250, 1300, 1350, 1400, 1450, or 1500 g.
  • an rOVA composition has a gel strength of about or at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100% relative to an egg white, nOVA or egg white substitutes.
  • an rOVA composition has a gel strength of up to 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100% relative to an egg white, nOVA or egg white substitutes.
  • rOVA compositions disclosed herein can provide structure, texture or a combination of structure and texture.
  • rOVA is added to a food ingredient or food product for baking and the rOVA provides structure, texture or a combination of structure and texture to the baked product.
  • rOVA can be used in such baked products in place of native egg white, native egg or native egg protein.
  • the addition of rOVA to baked products can also provide protein fortification to improve the nutritional content.
  • rOVA is used in a baked product in an amount between 0.1% and 25% on a weight/weight or weight/volume basis.
  • rOVA is used in a baked product in an amount between 0.1% and 5%.
  • rOVA provides the structure and/or texture of egg-white in absence of any other egg-white proteins.
  • rOVA compositions disclosed herein can be compatible with gluten formation, such that the rOVA can be used where gluten formation provides structure, texture and/or form to a food ingredient or food product.
  • Exemplary baked products in which rOVA can be used as an ingredient include, but are not limited to cake, cookie, bread, bagel, biscuits, muffin, cupcake, scone, pancake, macaroon, choux pastry, meringue, and souffle.
  • rOVA can be used as an ingredient to make cakes such as pound cake, sponge cake, yellow cake, or angel food cake, where such cakes do not contain any native egg white, native whole egg or native egg protein.
  • baked products may contain additional ingredients such as flour, sweetening agents, gum, hydrocolloids, starches, fibers, flavorings (such as flavoring extracts) and other protein sources.
  • a baked product may include rOVA and at least one fat or oil, at least one grain starch, and optionally at least one sweetener.
  • Grain starch for use in such compositions include flours such as wheat flour, rice flour, corn flour, millet flour, spelt flour, and oat flour, and starches such as from com, potato, sorghum, and arrowroot.
  • Oil and fat for use in such compositions include plant-derived oils and fats, such as olive oil, corn oil, avocado oil, nut oils (e.g., almond, walnut and peanut) and safflower oil.
  • rOVA may provide such baked goods with at least one characteristic of an egg white such as binding, springiness, aeration, browning, texturizing, humectant, and cohesiveness of the baked product.
  • the baked product does not comprise any natural egg white or natural egg, and/or does not include any other egg white derived proteins except rOVA.
  • rOVA is provided to the baked composition as an ingredient, such as starting with a concentrate, isolate or powder form of rOVA.
  • the rOVA provided as an ingredient for baked products is at a pH range between about 3.5 and 7.0.
  • a sweetener is included in the baked product such as a sugar, syrup, honey or sugar-substitute.
  • rOVA compositions disclosed herein can also be used to prepare egg-less food products, such as food products made where native whole egg or native egg white is a primary or featured ingredient such as scramble, omelet, patty, souffle, quiche and frittata.
  • rOVA provides one or more functional features to the preparation including foaming, coagulation, binding, structure, texture, film-formation, nutritional profile, absence of cholesterol (i.e., cholesterol free) and protein fortification.
  • Such egg-less preparations can be vegan, vegetarian, halal, or kosher, or a combination thereof.
  • An egg-less preparation may include rOVA and at least one fat or oil, a polysaccharide or polysaccharide-containing ingredient, and a starch.
  • the egg-less preparation may also include a flavoring agent (such as to provide a salty, sulfur-like or umami flavor), and/or a coloring agent (for example to provide yellow-like or off-white color to the baked product).
  • a flavoring agent such as to provide a salty, sulfur-like or umami flavor
  • a coloring agent for example to provide yellow-like or off-white color to the baked product.
  • the inclusion or rOVA in the egg-less preparation provides a characteristic of natural
  • (native) egg white such as hardness, adhesiveness, fracturability, cohesiveness, gumminess and chewiness when the composition is heated or cooked.
  • exemplary polysaccharide or polysaccharide-containing ingredients for such compositions include gellan gum, sodium alginate, and psyllium.
  • Oil and fat for use in such compositions include plant-derived oils and fats, such as olive oil, corn oil, avocado oil, and safflower oil.
  • rOVA compositions disclosed herein can be used for a processed meat product or meat like product, or for fish-like or shell-fish-like products.
  • rOVA can provide one or more functional characteristics such as protein content and protein supplementations as well as binding, texturizing properties.
  • Exemplary meat and meat-like products include burger, patty, sausage, hot dog, sliced deli meat, jerky, bacon, nugget and ground meat-like mixtures.
  • Meat-like products can resemble beef, pork, chicken, lamb and other edible and consumed meats for humans and for other animals.
  • Fish-like and shell-fish like products can resemble, for example, fish cakes, crab cakes, shrimp, shrimp balls, fish sticks, seafood meat, crab meat, fish fillets and clam strips.
  • rOVA is present in an amount between about 0.1% and 30% w/w/ or w/v in the meat or meat-like product.
  • rOVA is used for a meat-like product (also referred to as a meat-analog and includes at least one fat or oil; and a plant-derived protein.
  • Oil and fat for use in such compositions include plant-derived oils and fats, such as olive oil, corn oil, avocado oil, and safflower oil.
  • Plant-derived proteins for use in meat analogs include soy protein, nut proteins, pea protein, lentil and other pulse proteins and whey protein. In some cases, such plant protein is extruded, in other cases, such plant protein is non-extruded protein.
  • a meat analog include rOVA at about 2% to 15% (w/w).
  • rOVA acts as a binding agent, a gelling agent or a combination of a binding and gelling agent for such compositions.
  • rOVA compositions disclosed herein can be employed in coatings for food products.
  • rOVA can provide binding or adhesion characteristics to adhere batter or breading to another food ingredient.
  • rOVA can be used as an “egg-less egg wash” where the rOVA protein provides appearance, color and texture when coated onto other food ingredients or food products, such as baked products.
  • the “egg-less egg wash” may be used to coat a baked good such that the baked good adheres to a coating (e.g., seed, salt, spice, and herb).
  • a coating e.g., seed, salt, spice, and herb.
  • the addition of rOVA as a coating to a food product can provide a crunchy texture or increase the hardness, for example, of the exterior of a food product such as when the product is cooked, baked or fried.
  • rOVA compositions disclosed herein include sauces and dressings, such as an eggless mayonnaise, commercial mayonnaise substitutes, gravy, sandwich spread, salad dressing or food sauce. Inclusion of rOVA in a sauce or dressing, and the like, can provide one or more characteristics such as binding, emulsifying, odor neutrality, and mouthfeel. In some embodiments rOVA is present in such sauces and dressing in an amount between 0.1% and 3% or between about
  • the amount of rOVA in a sauce or dressing may be substantially similar to the amount of whole egg, egg-white or nOVA used in a commercially available or commonly used recipe.
  • Exemplary sauces and dressing include mayonnaise, commercial mayonnaise substitutes, alfredo sauce, and hollandaise sauce.
  • the rOVA-containing sauce or dressing does not contain whole egg, egg white, or any other protein extracted from egg.
  • the sauce, dressing or other emulsified product made with rOVA includes at least one fat or oil and water.
  • Exemplary fats and oils for such compositions include corn oil, safflower oil, nut oils, and avocado oil.
  • rOVA compositions can be used to prepare confectionaries such as eggless, animal-free, vegetarian and vegan confectionaries.
  • rOVA can provide one or more functional features to the confectionary including odor neutrality, flavor, mouthfeel, texture, gelling, cohesiveness, foaming, frothiness, nutritional value and protein fortification.
  • the prepared confectionary containing rOVA does not contain any native egg protein or native egg white.
  • rOVA in such confectionaries can provide a firm or chewy texture.
  • rOVA is present between about 0.1% and 15% in a confectionary.
  • Exemplary confectionaries include a gummy, a taffy, a divinity candy, meringue, marshmallow, and a nougat.
  • a confectionary includes rOVA, at least one sweetener and optionally a consumable liquid.
  • exemplary sweetners include sugar, honey, sugar-substitutes and plant-derived syrups.
  • the rOVA is provided as an ingredient for making confectionaries at a pH between about 3.5 and about 7.
  • the rOVA is present in the confectionary composition at about 2% to about 15% (w/v).
  • the confectionary is a food product such as a meringue, a whipped dessert, or a whipped topping.
  • rOVA in the confectionary provides foaming, whipping, fluffing or aeration to the food product, and/or provides gelation.
  • the confectionary is a liquid, such as a foamed drink.
  • the liquid may include a consumable alcohol (such as in a sweetened cocktail or after-dinner drink).
  • rOVA compositions herein can be used in dairy products, dairy-like products or dairy containing products.
  • rOVA can be used in preparations of beverages such as a smoothie, milkshake, “egg-nog”, and coffee beverage.
  • rOVA is added to additional ingredients where at least one ingredient is a dairy ingredient or dairy-derived ingredient
  • rOVA is added to additional ingredients to create a beverage that does not contain any native egg protein, native egg white or native egg.
  • rOVA is an ingredient in a beverage that does not contain any animal-derived ingredients, such as one that does not contain any native egg-derived or any dairy- derived ingredients. Examples of such non-dairy derived drinks include nut milks, such as soy milk or almond milk.
  • rOVA can also be used to create beverage additions, such as creamer or “milk” to provide protein, flavor, texture and mouthfeel to a beverage such as a coffee, tea, alcohol-based beverages or cocoa.
  • rOVA is present in a beverage ingredient or beverage addition in an amount between about 0.1% and 20% w/w or w/v.
  • rOVA can be used to prepare a dairy-like product such as yogurt, cheese or butter.
  • Dairy products with rOVA can include other animal-based dairy components or proteins.
  • dairy products prepared with rOVA do not include any animal-based ingredients.
  • Preparations of dessert products can be prepared using rOVA.
  • rOVA can provide one or more characteristics such as creamy texture, low fat content, odor neutrality, flavor, mouthfeel, texture, binding, and nutritional value.
  • rOVA may be present in an ingredient or set of ingredients that is used to prepare a dessert product.
  • Exemplary dessert products suitable for preparation with rOVA include a mousse, a cheesecake, a custard, a pudding, a popsicle and an ice cream.
  • dessert products prepared to include rOVA are vegan, vegetarian or dairy-free.
  • Dessert products that include rOVA can have an amount of rOVA that is between about 0.1% and about 10% rOVA w/w or w/v.
  • rOVA can be used to prepare a snack food, such as a protein bar, an energy bar, a nutrition bar or a granola bar.
  • the rOVA can provide characteristics to the snack food including one or more of binding, protein supplementation, flavor neutrality, odor neutrality, coating and mouth feel.
  • rOVA is added to a preparation of a snack food in an amount between about 0.1% and 30% w/w or w/v.
  • rOVA can be used for nutritional supplements such as in parenteral nutrition, protein drink supplements, protein shakes where rOVA provides a high protein supplement.
  • rOVA can be added to such compositions in an amount between about 10% and 30% w/w or w/v.
  • rOVA compositions can be used as an egg-replacer and an egg white-replacer.
  • rOVA can be mixed or combined with at least one additional component to form the egg white replacer.
  • rOVA can provide one or more characteristics to the egg-replacer or egg white-replacer, such as gelling, foaming, whipping, fluffing, binding, springiness, aeration, creaminess and cohesiveness.
  • characteristic is the same or better than a native egg or native egg white provided in the same amount or concentration (w/w or w/v).
  • the egg-replacer or egg white-replacer does not contain any egg, egg white, protein extracted or isolated from egg.
  • the rOVA-containing food ingredient and food products can contain additional ingredients or components.
  • rOVA compositions can be prepared with an additional component such as one or more of a sweetener, a gum, a flavoring, a thickener, an acidulant and an emulsifier.
  • Other ingredients such as flour, grains, oils and fats, fiber, fruit and vegetables can be combined with rOVA.
  • Such rOVA compositions can be vegan, vegetarian, halal, kosher and animal-free, or a combination thereof.
  • rOVA can be a food ingredient or prepared for a food product that is normally animal based or normally contains animal-derived components, such as meat, dairy or eggs.
  • compositions including rOVA including food ingredients and food products can be compatible with one or more steps of consumables preparation such as heated, baked, grilled, roasted, braised, microwaved, broiled, boiled, steamed, extruded, deep fried, or pan-fried, or processed using ohmic heating, Sue Vide, freezing, chilling, blanching, packaging, canning, bleaching, enriching, drying, pressing, grinding, mixing, par cooking, cooking, proofing, marinating, cutting, slicing, dicing, crushing, shredding, chopping, shaking, coring, spiralizing, rolling, juicing, straining, filtering, kneading, whisking, beating, whipping, grating, stuffing, peeling, smoking, curing, salting, preserving, pickling, fermenting, homogenizing, pasteurizing, sterilizing, irradiating, cold plasma processing, high pressure processing, pulse electric field processing, microwave assisted thermal sterilization, stabilizing, blending, puree
  • Food ingredients and food products prepared with rOVA can be essentially free of any microbial cells or microbial cell debris.
  • rOVA may be secreted from a microbial host cell and isolated from microbial cells, culture media and/or microbial cell debris.
  • rOVA may be prepared as a whole cell extract or fractionated extract such that an rOVA composition contains microbial cells and/or microbial cell components.
  • an rOVA composition is prepared for animal consumption where the rOVA is present in a whole cell extract or fractionated extract such that an rOVA composition contains microbial cells and/or microbial cell components.
  • an rOVA composition is prepared for animal consumption where rOVA is isolated from microbial cells, culture media and microbial cell debris.
  • Exemplary compositions for animal consumption can include a pet food, an animal feed, a chewy treat, bone broth, smoothie or other liquid for animal nutrition and a solid nutritional supplement suitable for animal consumption. In these cases, the microbial cell extract or microbial cell debris may provide additional nutritional value.
  • Animals which may consume rOVA compositions can include companion animals (e.g., dog, cat, horse), farm animals, exotic animals (lion, tiger, zebra) as well as livestock (such as cow, pig, sheep, goat).
  • rOVA compositions as described herein can also be used for aquaculture (such as for fish and shell fish) and for avian nutrition (such as for bird pets, zoo birds, wild birds, fowl and birds raised for human and animal food).
  • the composition is essentially free of animal-derived components, whey protein, caseinate, fat, lactose, hydrolyzed lactose, soy protein, collagen, hydrolyzed collagen, or gelatin, or any combination thereof.
  • a composition described herein may be essentially free of cholesterol, glucose, fat, saturated fat, trans fat, or any combination thereof.
  • a composition described herein comprises less than 10%, 5%, 4%, 3%, 2%, 1%, or 0.5% fat by dry weight.
  • the composition may be fat-containing (e.g., such as a mayonnaise and commercial mayonnaise substitutes) and such composition may include up to about 60% fat or a reduced-fat composition (e.g., reduced fat mayonnaise and commercial mayonnaise substitutes) and such composition may include lesser percentages of fat.
  • a composition that free of an animal-derived component can be considered vegetarian and/or vegan.
  • an rOVA powder composition comprises less than 5% ash.
  • ash is an art-known term and represents inorganics such as one or more ions, elements, minerals, and/or compounds
  • the rOVA powder composition comprises less than 5%, 4.5%, 4%, 3.5%, 3%, 2.5%, 2%, 1.5%, 1%, 0.75%, 0.5%, 0.25% or 0.1% ash weight per total weight (w/w) and/or weight per total volume (w/v).
  • the moisture content of an rOVA powder composition may be less than 15%.
  • the rOVA powder composition may have less than 15%, 12%, 10%, 8%, 6%, 5%, 3%, 2% or 1% moisture weight per total weight (w/w) and/or weight per total volume (w/v).
  • the carbohydrate content of an rOVA powder composition may be less than 30%.
  • the rOVA powder composition may have less than 30%, 27%, 25%, 22%, 20%, 17%, 15%, 12%, 10%, 8%, 5%, 3% or 1% carbohydrate content w/w or w/v.
  • the addition of rOVA to a consumable food composition provides increased protein nutritional content, sensory neutrality or an improved sensory appeal as compared to other proteins in such compositions.
  • sensor neutrality refers to the absence of a strong or distinctive taste, odor (smell) or combination of taste and smell, as well as texture, mouth-feel, aftertaste and color.
  • a sensory panel such as one described in Kemp et al. 2009 may be used by a trained sensory analyst.
  • Sensory neutrality may provide an improved sensory appeal to a taster, such as a tester of foods or a consumer, when a consumable food composition containing rOVA is compared with another like composition that has a different protein such as nOVA, whey protein, pea protein, soy protein, whole egg or egg white protein at the same concentration.
  • rOVA when added to a consumable food composition is substantially odorless, such as measured by a trained sensory analyst, in comparison with different solutions/products with a different protein component present in an equal concentration to the rOVA containing solution/product, for example, in the comparison is whey, soy, collagen, pea, egg white solid isolates and/or nOVA.
  • such compositions are essentially odorless at a protein concentration between about 0.5- 1%, l%-5%, 5-10%, 10-15%, 15-20%, 20-25%, 25-30% rOVA weight per total weight (w/w) and/or weight per total volume (w/v) or at a protein concentration of about 0.1, 1, 5, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30 g of total rOVA protein per 100 mL solution (e.g., per 100 mL water).
  • the addition of rOVA to a consumable food composition also provides a neutral taste in addition to the characteristics such as egg-white like properties and increased protein nutrition content.
  • a neutral taste can be measured for example, by a trained sensory analyst in comparison with solutions containing a different protein present in an equal concentration to the rOVA, for example, whey, soy, collagen, pea, whole egg, and egg white solid isolates (including native OVA).
  • the addition of rOVA provides a reduction in a certain odor and/or taste that is associated with other proteins or egg-whites.
  • addition of rOVA has less of an “egg-like” odor or taste as compared to the addition of whole egg, fractionated egg or egg- white to a consumable food composition.
  • addition of rOVA has less of a metallic odor or taste as compared to other protein sources.
  • the addition of rOVA has an improved mouth-feel as compared to the addition of other protein sources used to produce egg-white like properties.
  • the addition of rOVA is less grainy or has less precipitates or solids as compared to other protein sources.
  • the addition of rOVA has an improved texture, for example, as compared to other available supplemental protein sources.
  • a consumable composition with rOVA may also have an improved sensory appeal as compared to the composition without rOVA or with a different protein present in an equal concentration to the rOVA.
  • Such improved sensory appeal may relate to taste and/or smell.
  • Taste and smell can be measured, for example, by a trained sensory analyst.
  • a sensory analyst compares a consumable composition with rOVA to one without it or with a different protein or protein source in an equivalent amount.
  • a consumable composition herein can be in a liquid form.
  • a liquid form can be an intermediate product such as soluble rOVA solution.
  • a liquid form can be a final product, such as a beverage comprising rOVA.
  • Example of different types of beverages contemplated herein include: a juice, a soda, a soft drink, a flavored water, a protein water, a fortified water, a carbonated water, a nutritional drink, an energy drink, a sports drink, a recovery drink, an alcohol-based drink, a heated drink, a coffee-based drink, a tea-based drink, a plant-based milk, a nut milk, a milk based drink, a non-dairy, plant based mild drink, infant formula drink, and a meal replacement drink.
  • pH of Compositions pH of Compositions
  • the pH of an rOVA composition may be 3.5 to 8.
  • the pH of an rOVA composition may be at least 3.5.
  • the pH of an rOVA composition may be at most 8.
  • the pH of an rOVA composition may be 3.5 to 4, 3.5 to 4.5, 3.5 to 5, 3.5 to 5.5, 3.5 to 6, 3.5 to 6.5, 3.5 to 7, 3.5 to 7.5, 3.5 to 8, 4 to
  • the pH of an rOVA composition may be 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, or 8.
  • An rOVA composition with a pH between 3.5 to 7 may have one or more improved functionalities as compared to nOVA, egg white or egg-white substitute compositions.
  • the pH of an rOVA composition may be 2 to 3.5.
  • the pH of an rOVA composition may be at least 2.
  • the pH of an rOVA composition may be at most 3.5.
  • the pH of an rOVA composition may be 2 to 2.5, 2 to 3, 2 to 3.5, 2.5 to 3, 2.5 to 3.5, or 3 to 3.5.
  • the pH of an rOVA composition may be 2, 2.5, 3, or 3.5.
  • the pH of an rOVA composition may be 7 to 12.
  • the pH of an rOVA composition may be at least 7.
  • the pH of an rOVA composition may be at most 12.
  • the pH of an rOVA composition may be 7 to 7.5, 7 to 8, 7 to 8.5, 7 to 9, 7 to 9.5, 7 to 10, 7 to 10.5, 7 to 11, 7 to 11.5, 7 to 12, 7.5 to 8, 7.5 to 8.5, 7.5 to 9, 7.5 to 9.5, 7.5 to 10, 7.5 to 10.5, 7.5 to 11, 7.5 to 11.5, 7.5 to 12, 8 to 8.5, 8 to 9, 8 to 9.5, 8 to 10, 8 to 10.5, 8 to 11, 8 to 11.5, 8 to 12, 8.5 to 9, 8.5 to 9.5, 8.5 to 10, 8.5 to 10.5, 8 to 11, 8 to 11.5, 8 to 12, 8.5 to 9, 8.5 to 9.5, 8.5 to 10, 8.5 to
  • the pH of an rOVA composition may be 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 11.5, or 12.
  • the pH of rOVA may be adjusted prior to its inclusion in a composition or its use as an ingredient.
  • the pH of rOVA is adjusted during the purification and/or isolation processes.
  • the pH of the rOVA for use in an ingredient or in production of a food product composition is adjusted to between about 3.5 to about 7.0.
  • the pH of rOVA may be adjusted to more than one pH during the production process.
  • rOVA may be expressed in a host cell such as a a microbial cell, and in some cases the rOVA is secreted by the host cell into the growth media (e.g., liquid media). rOVA is separated from the host cells and such separation step may be performed at a selected pH, for example at a pH of about 3.5. In some cases, the rOVA at such separation pH may not be soluble or may not be fully soluble and the pH is adjusted to a higher pH, such as about pH 12.
  • the rOVA may then be adjusted to a final pH between about 3.5 and about 7.0. Separation of rOVA from other components of the host cells or other components of the liquid media can include one or more of ion exchange chromatography, such as cation exchange chromatography and/or anion exchange chromatography, filtration and ammonium sulfate precipitation.
  • the consumable food compositions containing rOVA disclosed herein and the methods of making such compositions may including adding or mixing the rOVA with one or more ingredients.
  • food additives may be added in or mixed with the compositions.
  • Food additives can add volume and/or mass to a composition.
  • a food additive may improve functional performance and/or physical characteristics.
  • a food additive may prevent gelation or increased viscosity due to the lipid portion of the lipoproteins in the freeze-thaw cycle.
  • An anticaking agent may be added to make a free-flowing composition.
  • Carbohydrates can be added to increase resistance to heat damage, e.g., less protein denaturation during drying and improve stability and flowability of dried compositions.
  • Food additives include, but are not limited to, food coloring, pH adjuster, natural flavoring, artificial flavoring, flavor enhancer, batch marker, food acid, filler, anticaking agent (e.g., sodium silico aluminate), antigreening agent (e.g., citric acid), food stabilizer, foam stabilizer or binding agent, antioxidant, acidity regulatory, bulking agent, color retention agent, whipping agent (e.g., ester-type whipping agent, triethyl citrate, sodium lauryl sulfate), emulsifier (e.g., lecithin), humectant, thickener, excipient, solid diluent, salts, nutrient, sweetener, glazing agent, preservative, vitamin, dietary elements, carbohydrates, polyol, gums, starches, flour, oil, or bran.
  • anticaking agent e.g., sodium silico aluminate
  • antigreening agent e.g., citric acid
  • Food coloring includes, but is not limited to, FD&C Yellow #5, FD&C Yellow #6, FD&C Red #40, FD&C Red #3, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, carotenoids (e.g., saffron, b-carotene), anthocyanins, annatto, betanin, butterfly pea, caramel coloring, chlorophyllin, elderberry juice, lycopene, carmine, pandan, paprika, turmeric, curcuminoids, quinoline yellow, carmoisine, Ponceau 4R, Patent Blue V, and Green S.
  • carotenoids e.g., saffron, b-carotene
  • anthocyanins e.g., saffron, b-carotene
  • anthocyanins e.g., saffron, b-carotene
  • Ingredients for pH adjustment include, but are not limited to, Tris buffer, potassium phosphate, sodium hydroxide, potassium hydroxide, citric acid, sodium citrate, sodium bicarbonate, and hydrochloric acid.
  • Salts include, but are not limited, to acid salts, alkali salts, organic salts, inorganic salts, phosphates, chloride salts, sodium salts, sodium chloride, potassium salts, potassium chloride, magnesium salts, magnesium chloride, magnesium perchlorate, calcium salts, calcium chloride, ammonium chloride, iron salts, iron chlorides, zinc salts, and zinc chloride.
  • Nutrient includes, but is not limited to, macronutrient, micronutrient, essential nutrient, non-essential nutrient, dietary fiber, amino acid, essential fatty acids, omega-3 fatty acids, and conjugated linoleic acid.
  • Sweeteners include, but are not limited to, sugar substitute, artificial sweetener, acesulfame potassium, advantame, alitame, aspartame, sodium cyclamate, dulcin, glucin, neohesperidin dihydrochalcone, neotame, P-4000, saccharin, aspartame-acesulfame salt, sucralose, brazzein, curculin, glycyrrhizin, glycerol, inulin, mogroside, mabinlin, malto-oligosaccharide, mannitol, miraculin, monatin, monellin, osladin, pentadin, stevia, trilobatin, and thaumatin.
  • Carbohydrates include, but are not limited to, sugar, sucrose, glucose, fructose, galactose, lactose, maltose, mannose, allulose, tagatose, xylose, arabinose, high fructose corn syrup, high maltose com syrup, corn syrup (e.g., glucose-free com syrup), sialic acid, monosaccharides, disaccharides, polysaccharides (e.g., polydextrose, maltodextrin), and starch.
  • Polyols include, but are not limited to, xylitol, maltitol, erythritol, sorbitol, threitol, arabitol, hydrogenated starch hydrolysates, isomalt, lactitol, mannitol, and galactitol (dulcitol).
  • Gums include, but are not limited to, gum arabic, gellan gum, guar gum, locust bean gum, acacia gum, cellulose gum, and xanthan gum.
  • Vitamins include, but are not limited to, niacin, riboflavin, pantothenic acid, thiamine, folic acid, vitamin A, vitamin B6, vitamin B12, vitamin D, vitamin E, lutein, zeaxanthin, choline, inositol, and biotin.
  • Dietary elements include, but are not limited to, calcium, iron, magnesium, phosphorus, potassium, sodium, zinc, copper, manganese, selenium, chlorine, iodine, sulfur, cobalt, molybdenum, nickel, and bromine.
  • Dietary elements include, but are not limited to, calcium, iron, magnesium, phosphorus, potassium, sodium, zinc, copper, manganese, selenium, chlorine, iodine, sulfur, cobalt, molybdenum, nickel, and bromine.
  • rOVA can have an amino acid sequence from any species.
  • an rOVA can have an amino acid sequence of OVA from a bird or a reptile or other egg-laying species.
  • An rOVA having an amino acid sequence from an avian can be selected from the group consisting of: poultry, fowl, waterfowl, game bird, chicken, quail, turkey, duck, ostrich, goose, gull, guineafowl, pheasant, emu, and any combination thereof.
  • An rOVA can have an amino acid sequence derived from a single species, such as Gallus gallus domesticus.
  • an rOVA can have an amino acid sequence derived from two or more species, and as such be a hybrid.
  • OVA amino acid sequences contemplated herein are provided in Table 1 below as SEQ ID NOs: 1-74.
  • rOVA expression of rOVA in a host cell, for instance a Pichia species, a Saccharomyces species, a Trichoderma species, a Pseudomonas species may lead to an addition of one or more amino acids to the OVA sequence as part of post-transcriptional or post-translational modifications. Such amino acids may not be part of the native OVA sequences.
  • expressing an OVA sequence in a Pichia species, such as Komagataella phaffii and Komagataella pastoris may lead to addition of one or more amino acids at the N-terminus or C-terminus.
  • EAEA (SEQ ID NO: 75) is added to the N-terminus of the OVA sequence upon expression in a host cell as shown in SEQ ID NO: 1.
  • chicken rOVA may be provided encoding SEQ ID NO: 1, and following expression and secretion, rOVA has the amino acid sequence of SEQ ID NO:2.
  • An rOVA can be a non-naturally occurring variant of an OVA. Such variant can comprise one or more amino acid insertions, deletions, or substitutions relative to a native OVA sequence.
  • Such a variant can have at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% sequence identity to SEQ ID NOs: 1-74.
  • sequence identity as used herein in the context of amino acid sequences is defined as the percentage of amino acid residues in a candidate sequence that are identical with the amino acid residues in a selected sequence, after aligning the sequences and introducing gaps, if necessary, to achieve the maximum percent sequence identity, and not considering any conservative substitutions as part of the sequence identity.
  • Alignment for purposes of determining percent amino acid sequence identity can be achieved in various ways that are within the skill in the art, for instance, using publicly available computer software such as BLAST, BLAST-2, ALIGN, ALIGN-2 or Megalign (DNASTAR) software, with BLAST being the preferable alignment algorithm. Those skilled in the art can determine appropriate parameters for measuring alignment, including any algorithms needed to achieve maximal alignment over the full- length of the sequences being compared. [0166] Depending on the host organism used to express the rOVA, the rOVA can have a glycosylation, acetylation, or phosphorylation pattern different from wildtype OVA.
  • the rOVA herein may or may not be glycosylated, acetylated, or phosphorylated.
  • An rOVA may have an avian, non-avian, microbial, non-microbial, mammalian, or non-mammalian glycosylation, acetylation, or phosphorylation pattern.
  • rOVA may be deglycosylated (e.g., chemically, enzymatically, Endo-H, PNGase F, O-Glycosidase, Neuraminidase, b1-4 Galactosidase, b-N-acetylglucosaminidase), deacetylated (e.g., protein deacetylase, histone deacetylase, sirtuin), or dephosphorylated (e.g., acid phosphatase, lambda protein phosphatase, calf intestinal phosphatase, alkaline phosphatase). Deglycosylation, deacetylation or dephosphorylation may produce a protein that is more uniform or is capable of producing a composition with less variation.
  • deglycosylation, deacetylation or dephosphorylation may produce a protein that is more uniform or is capable of producing a composition with less variation.
  • An rOVA is recombinantly expressed in a host cell.
  • a “host” or “host cell” denotes here any protein production host selected or genetically modified to produce a desired product.
  • exemplary hosts include fungi, such as filamentous fungi, as well as bacteria, yeast, plant, insect, and mammalian cells.
  • a host cell may be Arxula spp., Arxula adeninivorans , Kluyveromyces spp., Kluyveromyces lactis , Komagataella phaffii , Pichia spp., Pichia angusta, Pichia pastoris , Saccharomyces spp., Saccharomyces cerevisiae, Schizosaccharomyces spp., Schizosaccharomyces pombe , Yarrowia spp., Yarrowia lipolytica , Agaricus spp., Agaricus bisporus , Aspergillus spp., Aspergillus awamori , Aspergillus fumigatus , Aspergillus nidulans , Aspergillus niger , Aspergillus oryzae, Bacillus subtilis , Colletotrichum spp., Colle
  • An rOVA protein can be recombinantly expressed in yeast, filamentous fungi or a bacterium.
  • rOVA protein is recombinantly expressed in a Pichia species ( Komagataella phaffii and Komagataella pastoris ), a Saccharomyces species, a Trichoderma species, a Pseudomonas species or an E.coli species.
  • Expression of an rOVA can be provided by an expression vector, a plasmid, a nucleic acid integrated into the host genome or other means.
  • a vector for expression can include: (a) a promoter element, (b) a signal peptide, (c) an OVA sequence heterologous to the host cell, and (d) a terminator element.
  • Expression vectors that can be used for expression of OVA include those containing an expression cassette with elements (a), (b), (c) and (d).
  • the signal peptide (b) need not be included in the vector.
  • the expression cassette is designed to mediate the transcription of the transgene when integrated into the genome of a cognate host microorganism.
  • a replication origin (e) may be contained in the vector (such as PUC ORIC and PUC (DNA2.0)).
  • the vector may also include a selection marker (f) such as URA3 gene and Zeocin resistance gene (ZeoR).
  • the expression vector may also contain a restriction enzyme site (g) that allows for linearization of the expression vector prior to transformation into the host microorganism to facilitate the expression vectors stable integration into the host genome.
  • the expression vector may contain any subset of the elements (b), (e), (f), and (g), including none of elements (b), (e), (f), and (g).
  • Other expression elements and vector element known to one of skill in the art can be used in combination or substituted for the elements described herein.
  • Exemplary promoter elements (a) may include, but are not limited to, a constitutive promoter, inducible promoter, and hybrid promoter. Promoters include, but are not limited to, acu- 5, adhl+, alcohol dehydrogenase (ADH1, ADH2, ADH4), AHSB4m, AINV, alcA, a-amylase, alternative oxidase (AOD), alcohol oxidase I (AOX1), alcohol oxidase 2 (AOX2), AXDH, B2, CaMV, cellobiohydrolase I (cbhl), ccg-1, cDNAl, cellular filament polypeptide (cfp), cpc-2, ctr4+, CUP1, dihydroxyacetone synthase (DAS), enolase (ENO, ENOl), formaldehyde dehydrogenase (FLD1), FMD, formate dehydrogenase (FMDH), Gl, G6, GAA, G
  • a signal peptide (b) also known as a signal sequence, targeting signal, localization signal, localization sequence, signal peptide, transit peptide, leader sequence, or leader peptide, may support secretion of a protein or polynucleotide. Extracellular secretion of a recombinant or heterologously expressed protein from a host cell may facilitate protein purification.
  • a signal peptide may be derived from a precursor (e.g., prepropeptide, preprotein) of a protein. Signal peptides can be derived from a precursor of a protein other than the signal peptides in native OVA.
  • secretion protein is a S. cerevisiae alpha factor pre pro sequence shown bolded and underlined in SEQ ID NO: 1.
  • Any nucleic acid sequence that encodes OVA can be used as (c).
  • Preferably such sequence is codon optimized for the host cell.
  • Exemplary transcriptional terminator elements include, but are not limited to, acu-5, adhl+, alcohol dehydrogenase (ADH1, ADH2, ADH4), AHSB4m, AINV, alcA, a-amylase, alternative oxidase (AOD), alcohol oxidase I (AOX1), alcohol oxidase 2 (AOX2), AXDH, B2, CaMV, cellobiohydrolase l (cbhl), ccg-1, cDNAl, cellular filament polypeptide (cfp), cpc-2, ctr4+, CUP1, dihydroxyacetone synthase (DAS), enolase (ENO, ENOl), formaldehyde dehydrogenase (FLD1), FMD, formate dehydrogenase (FMDH), Gl, G6, GAA, GALl, GAL2, GAL3, GAL4, GAL5, GAL6, GAL7, GAL8, GAL9,
  • Exemplary selectable markers (f) may include, but are not limited to: an antibiotic resistance gene (e.g. zeocin, ampicillin, blasticidin, kanamycin, nourseothricin, chloroamphenicol, tetracycline, triclosan, ganciclovir, and any combination thereof), an auxotrophic marker (e.g. adel, arg4, his4, ura3, met2, and any combination thereof).
  • an antibiotic resistance gene e.g. zeocin, ampicillin, blasticidin, kanamycin, nourseothricin, chloroamphenicol, tetracycline, triclosan, ganciclovir, and any combination thereof
  • an auxotrophic marker e.g. adel, arg4, his4, ura3, met2, and any combination thereof.
  • a vector for expression in Pichia sp. can include an AOX1 promoter operably linked to a signal peptide (alpha mating factor) that is fused in frame with a nucleic acid sequence encoding OVA, and a terminator element (AOX1 terminator) immediately downstream of the nucleic acid sequence encoding OVA.
  • AOX1 promoter operably linked to a signal peptide (alpha mating factor) that is fused in frame with a nucleic acid sequence encoding OVA, and a terminator element (AOX1 terminator) immediately downstream of the nucleic acid sequence encoding OVA.
  • a vector comprising a DAS1 promoter is operably linked to a signal peptide (alpha mating factor) that is fused in frame with a nucleic acid sequence encoding OVA and a terminator element (AOX1 terminator) immediately downstream of OVA.
  • a signal peptide alpha mating factor
  • a recombinant protein described herein may be secreted from the one or more host cells.
  • rOVA protein is secreted from the host cell.
  • the secreted rOVA may be isolated and purified by methods such as centrifugation, fractionation, filtration, ion exchange chromatography, affinity purification and other methods for separating protein from cells, liquid and solid media components and other cellular products and byproducts.
  • rOVA is produced in a Pichia Sp. and secreted from the host cells into the culture media. The secreted rOVA is then separated from other media components for further use.
  • the present disclosure contemplates modifying glycosylation of the recombinant OVA to alter or enhance one or more functional characteristics of the protein and/or its production.
  • the change in rOVA glycosylation can be due to the host cell glycosylating the rOVA.
  • rOVA has a glycosylation pattern that is not identical to a native ovalbumin (nOVA), such as a nOVA from chicken egg.
  • nOVA native ovalbumin
  • rOVA is treated with a deglycosylating enzyme before it is used as an ingredient in an rOVA composition, or when rOVA is present in a composition.
  • the glycosylation of rOVA is modified or removed by expressing one or more enzymes in a host cell and exposing rOVA to the one or more enzymes.
  • rOVA and the one or more enzymes for modification or removal of glycosylation are co-expressed in the same host cell.
  • Native ovalbumin such as isolated from a chicken or another avian egg, has a highly complex branched form of glycosylation.
  • the glycosylation pattern comprises N-linked glycan structures such as N-acetylglucosamine units, galactose and N-linked mannose units. See, e.g., FIG. 1A.
  • the rOVA for use in a herein disclosed consumable composition and produced using the methods described herein has a glycosylation pattern which is different from the glycosylation pattern of nOVA.
  • FIG. IB illustrates the glycosylation patterns of rOVA produced by P. pastoris, showing a complex branched glycosylation pattern.
  • rOVA is treated such that the glycosylation pattern is modified from that of nOVA and also modified as compared to rOVA produced by a Pichia sp. without such treatment. In some cases, the rOVA lacks glycosylation.
  • the molecular weight or rOVA may be different as compared to nOVA.
  • the molecular weight of the protein may be less than the molecular weight of nOVA or less than rOVA produced by the host cell where the glycosylation of rOVA is not modified.
  • the molecular weight of an rOVA may be between 40kDa and 55kDa.
  • an rOVA with modified glycosylation has a different molecular weight, such as compared to a native OVA (as produced by an avian host species) or as compared to a host cell that glycosylates the rOVA, such as where the rOVA includes N-linked mannosylation.
  • the molecular weight of rOVA is greater than the molecular weight of the rOVA that is completely devoid of post-translational modifications or an rOVA that lacks all forms of N-linked glycosylation.
  • Ranges can be expressed herein as from “about” or “approximately” one particular value, and/or to “about” or “approximately” another particular value. When such a range is expressed, another case includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about” or “approximately”, it will be understood that the particular value forms another case. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint.
  • a Gallus gallus OVA coding sequence was fused in-frame with the alpha mating factor signal sequence downstream of the promoter sequence (SEQ ID NO:l).
  • a promoter was placed upstream of the signal sequence OVA coding sequence and a transcriptional terminator was placed downstream of the OVA sequence.
  • the expression construct was placed into a Kpas-URA 3 vector.
  • Fermentation Recombinant OVA was produced in a bioreactor at ambient conditions.
  • a seed train for the fermentation process begins with the inoculation of shake flasks with liquid growth broth using 2ml cryovials of Pichia pastoris which are stored at -80°C and thawed at room temperature prior to inoculation.
  • the culture was grown at 30°C, at a set pH and dissolved oxygen (DO).
  • DO dissolved oxygen
  • the culture was fed with a carbon source.
  • the target OVA protein was harvested from the supernatant.
  • Example 2 Preparation of an eggless cake using recombinant ovalbumin
  • An eggless pound cake can be prepared with the following ingredients.
  • a first ingredient composition made by mixing 2% to 5% recombinant ovalbumin and 0.05% to 0.5% sunflower lecithin.
  • To prepare the pound cake up to 4% of the dry first ingredient composition is added to 22 - 26% of unsalted butter, 20 - 25% of all-purpose flour, 18 - 26% of water, 20 - 25% sugar, 4 - 6% of sour cream, 1.2% of baking powder, 0.4% of vanilla flavor, 0.05 to 1.5% gums and starch and 0.18% of salt and all ingredients are then mixed to create a batter.
  • recombinant ovalbumin may be used at 2-5% and sunflower lecithin from 0.05 to 0.5%.
  • Table 4 Cake with rOVA+ Potato Starch+ Xanthan gum [0197]
  • the batter was baked at 325°F until cooked such time that a toothpick, when inserted at the middle of the cake, came out clean.
  • Texture qualities such as cohesiveness, resilience, hardness, chewiness and springiness were measured using a Brookfield CT3 Texture analyzer, 1500g load cell. No significant difference was observed between the Control Egg cakes and cakes made with rOVA in terms of textural properties and cake height. The sensory properties were comparable to the Control cake made with whole egg.
  • Equipment Kitchen Aid, Classic Plus, Breville BOV800XL Smart Electric Oven.
  • Exemplary meringue recipes using rOVA can include rOVAbetween 5-10%, sugar at about 26-32%, flavoring (e.g., 1-4%), water at about 59-64%, xanthan gum at about 0.01-0.5%, sodium lauryl sulfate at about 0.01-0.1% (all w/w).
  • rOVA between 5-10%, sugar at about 26-32%, flavoring (e.g., 1-4%), water at about 59-64%, xanthan gum at about 0.01-0.5%, sodium lauryl sulfate at about 0.01-0.1% (all w/w).
  • exemplary recipe, and comparison recipes with fresh egg white or with native OVA or with rOVA was constructed as shown below:
  • This example evaluated the foam capacity/stability and coagulation properties of rOVA and compared it to fresh whole egg, egg white and nOVA.
  • a stock solution of OVA (nOVA or rOVA) was made by mixing 0.7 g OVA in 9.3g distilled water (total volume 10 ml). Cream of tartar was used (see Table 10 below) to adjust pH. Foam was made using a Dremel at speed 3. The time of whisking was recorded. Gel was made by heating 1 ml of sample at 72°C for lOmin using a heat block.
  • the first three cassettes were made to express a chicken OVA that comprises the amino acid sequence of chicken OVA (SEQ ID NO:2) fused in-frame with a nucleic acid encoding a secretion signal sequence; the expressed fusion protein has the amino acid sequence of (SEQ ID NO: 1).
  • the Alcohol oxidase 1 (AOX1) promoter was placed upstream of the secretion signal sequence and a K phaffii AOX1 transcriptional terminator was placed downstream of the OVA-encoding sequence.
  • These cassettes were labeled GgOVA-Al, GgOVA ⁇ A2, and GgOVA-A3 and combined into a first plasmid.
  • the fourth cassette included a chicken OVA coding sequence (which encodes SEQ ID NO: 2) fused in-frame with a nucleic acid encoding a secretion signal sequence (thereby encoding SEQ ID NO: 1) but with a dihydroxyacetone synthase (DAS2) promoter placed upstream of the secretion signal sequence and a K phaffii AOX1 transcriptional terminator placed downstream of the OVA-encoding sequence.
  • DAS2 dihydroxyacetone synthase
  • the fifth and sixth cassettes included the chicken OVA coding sequence (which encodes SEQ ID NO: 2) fused in-frame with a nucleic acid encoding a secretion signal sequence (thereby encoding SEQ ID NO: 1) but with a formaldehyde dehydrogenase (FLD) promote placed upstream of the secretion signal sequence and a K phaffii AQX1 transcriptional terminator placed downstream of the OVA-encoding sequence.
  • FLD formaldehyde dehydrogenase
  • the seventh cassette included the peroxisome biogenesis (PEX11) promoter placed upstream of a Helper factor protein HAC1 coding sequence and a K. phaffii AOX1 transcriptional terminator placed downstream of the Helper factor sequence. This cassette was labeled HF-1 and was transformed into a third plasmid.
  • PEX11 peroxisome biogenesis
  • Example 6 Preparation of recombinant ovalbumin expression strains for Duck and Ostrich
  • Expression Constructs one cassette for expression of Anas platyrhynchos (duck) OVA and one cassette for expression of Struthio camelus (ostrich) OVA were created for expression in Pichia pastoris.
  • One expression cassette was created for the expression of ostrich OVA.
  • a nucleic acid encoding Struthio camelus OVA (SEQ ID NO: 71) was fused in-frame with a nucleic acid encoding a secretion signal sequence (thereby encoding SEQ ID NO: 72).
  • the ostrich construct included the Alcohol oxidase 1 (AOX1) promoter placed upstream of the secretion signal sequence and a K phaffii AQXI transcriptional terminator was placed downstream of the OVA sequence.
  • This expression cassette called ScOVA was transformed into Pichia pastoris. Successful integration of four copies of the ostrich OVA construct was confirmed by genomic sequencing. See Table 15.
  • One expression cassette was created for the expression of duck OVA.
  • a nucleic acid encoding Anas platyrhynchos OVA (SEQ ID NO: 73) was fused in-frame with a nucleic acid encoding a secretion signal sequence (thereby encoding SEQ ID NO: 74).
  • the duck cassette included the Alcohol oxidase 1 (AOX1) promoter placed upstream of the secretion signal sequence and a K phaffii AOX1 transcriptional terminator was placed downstream of the OVA sequence.
  • This expression cassette called ApdOVA was transformed into Pichia pastoris. Successful integration of two copies of the duck OVA construct was confirmed by genomic sequencing. See,
  • Fermentation Strains for fermenting recombinant OVA (rOVA) were each cultured in a bioreactor at ambient conditions. A seed train for the fermentation process began with the inoculation of shake flasks with liquid growth broth. The inoculated shake flasks were kept in a shaker after which the grown P. pastoris was transferred to a production- scale reactor.
  • rOVA recombinant OVA
  • a seed vial of rOVA 1 pastoris seed strain was removed from cryo- storage and thawed to room temperature. Contents of the thawed seed vials were used to inoculate liquid seed culture media in baffled flasks which were grown at 30°C in shaking incubators. These seed flasks were then transferred and grown in a series of larger and larger seed fermenters (number to vary depending on scale) containing a basal salt media, trace metals, and glucose. Temperature in the seed reactors was controlled at 30°C, pH at 5, and dissolved oxygen (DO) at 30%. pH was maintained by feeding ammonia hydroxide, which also acted as a nitrogen source. Once sufficient cell mass was reached, the grown rOVA 1 pastoris was inoculated into a production- scale reactor containing basal salt media, trace metals, and glucose.
  • the culture was also controlled at 30°C, pH5 and 30% DO throughout the process. pH was again maintained by feeding ammonia hydroxide.
  • the culture was left to consume all glucose and subsequently-produced ethanol.
  • the glucose fed-batch growth phase was initiated. In this phase, glucose was fed until the culture reached a target cell density. Glucose was fed at a limiting rate to prevent ethanol from building up in the presence of non-zero glucose concentrations.
  • the culture was co-fed glucose and methanol which induced it to produce rOVA via the pAOX promoters.
  • Glucose was fed at an amount to produce a desired growth rate, while methanol was fed to maintain the methanol concentration at 1% to ensure that expression was consistently induced. Regular samples were taken throughout the fermentation process for analyses of specific process parameters (e.g., cell density, glucose/methanol concentrations, product titer, and quality). After a designated amount of fermentation time, secreted rOVA was collected and transferred for downstream processing.
  • specific process parameters e.g., cell density, glucose/methanol concentrations, product titer, and quality.
  • the fermentation broth containing the secreted rOVA was subjected to centrifugation at 12,000rpm. The supernatant was clarified using microfiltration. To concentrate the protein and remove excess water, ultrafiltration at room temperature was used. An appropriately sized filter was used to retain the target rOVA while the compounds, salts, and water smaller than rOVA passed through the filter. To reduce the final salt content and conductivity in preparation for chromatography, the concentrated rOVA retentate was dialyzed at pH 3.5 until the final conductivity of the material was 1.7mS/cm. The bulk of the purification was done using cation exchange chromatography at pH 3.5.
  • Citrate buffer containing a high salt concentration of sodium chloride was used to elute the bound rOVA from the resin. To remove the excess salts, the eluant was finally dialyzed to make a final protein solution containing about 5-10% protein and 85-95% water. The final solution was sterilized by passing it through a 0.2um bioburden filter. The water was evaporated using a spray dryer/lyophilizer at appropriate temperatures to produce a final powder containing about 80% protein.
  • hydrophobic recombinant chicken rOVA was solubilized and passed through a 0.2pm filter.
  • Recombinant rOVA was purified through ion exchange chromatography at pH 3.5 and was found to be insoluble. Sodium hydroxide was added to the solution to change the pH to 12.5 and solubilize the rOVA. The rOVA solution at pH 12.5 was passed through a 0.2pm filter. Following filtration, the pH was returned to 6.5 using hydrochloric acid and the rOVA was spray dried or lyophilized. This dried chicken rOVA was then used in the Examples below.
  • Pichia- secreted rOVA was analyzed for glycosylation patterns.
  • nOVA Native ovalbumin
  • FIG. 1A A single site of glycosylation at Asn-292 is found in the egg white.
  • MALDI-TOF analysis has shown that the typical glycans on native OVA are organized as (Man)5(GlcNAc)5(Gal)l (FIG. 1A) (Harvey et ah, 2000). Analysis of glycans on rOVA showed a typical glycosylation pattern shown in (FIG. IB).
  • Pichia secreted chicken rOVA was subjected to standard analysis using Mass spectrometry. It was found to have five versions of N-linked Glycans (ManGlcNAc): high-mannose glycans of Man9 (-40%), ManlO ( ⁇ 47%) or Manl 1 (-13%) type of N-glycan structures (FIG. 6B).
  • ManGlcNAc N-linked Glycans
  • Example 10 Comparison of foaming functionalities of various species rOVA
  • chicken rOVA, duck rOVA and ostrich rOVA were evaluated for properties of foaming ability and foam retention.
  • rOVA from ostrich and duck were produced, purified and lyophilized using methods similar to those set forth in Example 5 to 7.
  • the ostrich rOVA and duck rOVA remained close to the acidic pH used for purification.
  • Chicken rOVA was produced as set forth in Example 5 and solubilized at pH 12 before removing bioburden and returned to pH 6 before drying as set forth in Example 7.
  • Chicken nOVA quickly formed stiff white foam. Ostrich rOVA foamed after 15 seconds. Duck rOVA foamed after 20 seconds.
  • Table 17 Foaming Parameters for rOVA in various species [0243] Table 17 shows the results for foaming time, foaming capacity, foam stability for chicken nOVA, at pH 5.87, chicken rOVA at pH 6.49 and pH 6.08, ostrich rOVA at pH 3.7 and pH 5.73, duck rOVA at pH 4 .3 and egg white OVA at pH 9.0.
  • Recombinant OVA from chicken, duck and ostrich generally had a similar or improved foaming capacity and foam stability as compared to egg white and these recombinant OVA proteins provided foaming capacity and foam stability between at least pH 3.5 and 6.5.
  • Foam capacity and foam stability of rOVAs provide utility in compositions such as baked compositions.
  • FIG. 7 shows the results for gelation before and after foaming for chicken nOVA, at pH 5.87, chicken rOVA at pH 6.49 and pH 6.08, ostrich rOVA at PH 3.7 and pH 5.73, duck rOVA at pH 4.3 and egg white OVA at pH 9.0.
  • Duck rOVA showed better gelation characteristics compared to chicken rOVA.
  • Duck rOVA had gelation functionality close to that of natural egg white.
  • Protein solutions were created for each 4% rOVA, 7% rOVA, Fresh Egg White (12% protein), and 12% rOVA. Percent protein of the powders was used in the calculations to determine the amount necessary for each solution. 1 mL of each solution was reserved before validation in a microtube for later use to test gelation. The samples were divided into 5mL aliquots to be tested for foam capacity and stability.
  • rOVA at 4%, 7% and 12% has greater foaming capacity, more foaming stability, and forms a foam more quickly than fresh egg white.
  • Example 13 Browning and sheen properties of rOVA
  • Baking instructions Yeast, sugar and warm water were mixed together in a small bowl and left to sit for five minutes. Flour was mixed into the yeast solution (30 seconds) until a firm dough was formed (mixed for 2 minutes at speed 3). Dough was kneaded on a floured board, placed into a greased bowl and left to rise for 45 minutes at 80°F. Dough was kneaded again, shaped into a 25g mini loaf, and placed in a greased pan. The mini loaf was covered and allowed to rise for 30 minutes at room temperature. A volume of 0.75g of the appropriate wash was applied to the top of the dough balls. Mini loaves were baked at 350°F for eight minutes or until golden brown. Bread loaves’ locations were switched in the oven at four minutes to achieve even baking of all samples.
  • Table 20 Ingredients used in wash formulations:
  • Colorimetric assay Individual sample pictures were analyzed for color data in the RGB spectrum using the Colorgrab application (Loomatix). Sample values were generated using a 2x2 cm cross-section taken from the center of the bread surface. RGB data was then converted to a CIELAB system using the online software www.colormine.org. CIELAB model is a color space system that expresses color in 3 values: L* for the lightness from black (0) to white (100), a* from green (-) to red (+), h* from blue (-) to yellow (+).
  • Table 21 CIELAB results for bread post baking: [0258] rOVA and egg white protein samples had a higher L* value suggesting higher brightness or luminance. Control (no egg wash), commercial egg wash substitute and egg white protein samples had a low a* value suggesting lower redness or brownness as compared to whole egg, and rOVA samples. 8% egg white protein and rOVA samples also had similar b* values, suggesting similar yellow hues as compared to the other samples.
  • rOVA was evaluated for the film formation property of adhesiveness functionality in a bread application creating a uniform film to aid addition of toppings (e.g., sesame seeds).
  • Retention of sesame seeds Retention of any topping on cake, bread, bagels or other baked goods is an intended consequence of an egg wash. Sesame seeds were used to evaluate the toping retention function of each film forming agent after baking.
  • Dough balls and protein of interest were prepared as Example 13. Ten sesame seeds were applied to each dough ball after the application of wash and before baking. Retention of these sesame seeds was calculated based on the amount of seeds stuck to the bread after baking.
  • the foaming functionality of rOVA was observed in an alcohol-based drink (e.g., such as a Whiskey Sour which includes a foaming agent).
  • an alcohol-based drink e.g., such as a Whiskey Sour which includes a foaming agent.
  • Bourbon whisky, fresh lemon juice, simple syrup, and protein of interest were combined in a cocktail shaker and shaken for 15 seconds. Ice was added to the cocktail shaker and the mixture shaken for another 15 seconds. Shaken mixture was poured into a glass and observed.
  • Control formulation included natural egg white.
  • the negative formulation was prepared without any egg white.
  • Table 26 List of ingredients and the formulations
  • the proteins of interest were used to substitute the natural egg white protein and the following formulations were used:
  • the objective of this example was to evaluate the binding functionality of rOVA. Parameters such as appearance (how well the burger held together), textural aspects such as cohesiveness, springiness, chewiness and hardness were evaluated and compared against egg white, nOVA and commercially used non-protein binder.
  • the blend was chilled in the freezer for 10 minutes.
  • the binding agent was added and mixed in for 30 seconds.
  • Canola and coconut oil blend was added and mixed for 30 seconds.
  • the mixture was chilled in the freezer for 5 minutes, then molded into 5g burger forms and frozen.
  • Texture Analysis was performed to analyze the attributes of vegan burgers against the control. Texture analysis was used to quantify hardness attributes along with cohesiveness, springiness and chewiness.
  • the frozen samples were thawed in the refrigerator to a 4°C internal temperature and tested for raw binding.
  • the thawed samples were also cooked and used to measure the cooked binding values.
  • Example 18 Egg white patty
  • Cooking A griddle was used to cook the samples. The griddle was set to 250 °F and 1 ⁇ 2 inch diameter ring molds were used to cook samples. The molds were sprayed with oil and the mixture was poured into the molds. 1/2 ice cubes were added to the molds to generate steam. The patties were allowed to cook and another ice cube was added. The patties were cooked for 5 minutes and the lid was opened. The ring molds with the cooked samples to serving plates.
  • Table 33 Test parameters used for TPA test to measure textural properties of patty:
  • EWP and rOVA both gelled at pH 6-9; however, EWP gels were stronger and firmer than rOVA gels.
  • EWP exhibited better gelling properties than rOVA over a broader pH spectrum, it came with the presence of a strong egg-like smell.
  • rOVA provided gelling properties in the pH 6-8 range and provided sensory neutrality (e.g., no smell).
  • rOVA provided clear firm gel which can have unique value proposition in embodiments requiring transparent visual appearance.
  • rOVA was used as a protein source in a protein bar application and compared to eff white proteins and nOVA.
  • Table 40 List of Ingredients and their proportions used in egg white protein formulations:
  • Table 41 List of Ingredients and their proportions used in nOVA formulations:
  • Table 42 List of Ingredients and their proportions used in rOVA formulations:
  • Table 43 Test parameters used for three-point bend test to measure hardness of crackers using a CT3 Brookfield Texture Analyzer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Confectionery (AREA)
PCT/US2020/047076 2019-07-11 2020-08-19 Non-animal based protein sources with functional properties Ceased WO2021034980A1 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
FI20225221A FI20225221A1 (en) 2019-08-19 2020-08-19 Non-animal based protein sources with functional properties
BR112022003241A BR112022003241A2 (pt) 2019-08-19 2020-08-19 Fontes de proteína não animal com propriedades fucionais
CA3145805A CA3145805A1 (en) 2019-08-19 2020-08-19 Non-animal based protein sources with functional properties
HRP20250291TT HRP20250291T1 (hr) 2019-08-19 2020-08-19 Neživotinjski izvori proteina s funkcionalnim svojstvima
GB2203397.1A GB2605017B (en) 2019-08-19 2020-08-19 Non-animal based protein sources with functional properties
EP20855636.5A EP4017287B1 (en) 2019-08-19 2020-08-19 Non-animal based protein sources with functional properties
KR1020227009006A KR20220047845A (ko) 2019-08-19 2020-08-19 기능적 특성을 가진 비동물성 단백질 공급원
AU2020331967A AU2020331967A1 (en) 2019-08-19 2020-08-19 Non-animal based protein sources with functional properties
ES20855636T ES3014359T3 (en) 2019-08-19 2020-08-19 Non-animal based protein sources with functional properties
MX2022002051A MX2022002051A (es) 2019-08-19 2020-08-19 Fuentes de proteina de origen no animal con propiedades funcionales.
EP24218433.1A EP4559323A3 (en) 2019-08-19 2020-08-19 Non-animal based protein sources with functional properties
CN202080073303.XA CN114599234A (zh) 2019-08-19 2020-08-19 具有功能性能的非动物性蛋白质来源
FIU20234006U FI13394Y1 (fi) 2019-08-19 2020-08-19 Munaton ruokatuote ja leivottu ruokatuote
JP2022510139A JP2022546260A (ja) 2019-08-19 2020-08-19 機能的性質を有する非動物系タンパク質源
US17/508,064 US20220039443A1 (en) 2019-08-19 2021-10-22 Non-animal based protein sources with functional properties
IL290550A IL290550A (en) 2019-08-19 2022-02-10 Non-animal based protein sources with functional properties
DKPA202270112A DK182004B1 (en) 2019-08-19 2022-03-18 AN EGG-LESS FOOD ITEM COMPRISING AN INGREDIENT COMPOSITION COMPRISING A RECOMBINANT OVALBUMIN (rOVA)
US18/045,425 US20230189857A1 (en) 2019-08-19 2022-10-10 Recombinant proteins with functional properties
US18/614,611 US12096784B2 (en) 2019-07-11 2024-03-22 Protein compositions and consumable products thereof
US18/766,643 US20250212928A1 (en) 2019-07-11 2024-07-08 Protein compositions and consumable products thereof
JP2025065554A JP2025100711A (ja) 2019-08-19 2025-04-11 機能的性質を有する非動物系タンパク質源
US19/288,654 US20260020590A1 (en) 2019-08-19 2025-08-01 Non-animal based protein sources with functional properties

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962888674P 2019-08-19 2019-08-19
US62/888,674 2019-08-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/508,064 Continuation US20220039443A1 (en) 2019-07-11 2021-10-22 Non-animal based protein sources with functional properties

Publications (1)

Publication Number Publication Date
WO2021034980A1 true WO2021034980A1 (en) 2021-02-25

Family

ID=74659544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2020/047076 Ceased WO2021034980A1 (en) 2019-07-11 2020-08-19 Non-animal based protein sources with functional properties

Country Status (17)

Country Link
US (3) US20220039443A1 (https=)
EP (2) EP4559323A3 (https=)
JP (2) JP2022546260A (https=)
KR (1) KR20220047845A (https=)
CN (1) CN114599234A (https=)
AU (1) AU2020331967A1 (https=)
BR (1) BR112022003241A2 (https=)
CA (1) CA3145805A1 (https=)
DE (1) DE202020005912U1 (https=)
DK (3) DK182004B1 (https=)
ES (1) ES3014359T3 (https=)
FI (2) FI20225221A1 (https=)
GB (2) GB2605017B (https=)
HR (1) HRP20250291T1 (https=)
IL (1) IL290550A (https=)
MX (1) MX2022002051A (https=)
WO (1) WO2021034980A1 (https=)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022076615A1 (en) * 2020-10-06 2022-04-14 Clara Foods Co. Protein compositions and consumable products thereof
WO2022226176A3 (en) * 2021-04-23 2022-12-01 Plantible Foods Inc. Ribulose-1,5-bisphosphate carboxylate-oxygenase (rubisco) protein isolate compositions for plant-based egg replacement products and plant-based milk replacement products
WO2023004153A1 (en) * 2021-07-23 2023-01-26 Clara Foods Co. Purified protein compositions and methods of production
WO2023102214A1 (en) * 2021-12-03 2023-06-08 Mars, Incorporated Food product
US11685928B2 (en) 2020-09-30 2023-06-27 Nobell Foods, Inc. Recombinant fusion proteins for producing milk proteins in plants
WO2023148340A1 (fr) * 2022-02-03 2023-08-10 Algama Composition de substitution aux œufs pour la préparation d'un substitut végétalien à l'omelette ou aux œufs brouillés
US11800887B2 (en) 2019-07-11 2023-10-31 Clara Foods Co. Protein compositions and consumable products thereof
US11840717B2 (en) 2020-09-30 2023-12-12 Nobell Foods, Inc. Host cells comprising a recombinant casein protein and a recombinant kinase protein
CN117979833A (zh) * 2021-07-23 2024-05-03 克莱拉食品公司 纯化的蛋白组合物及生产方法
US12016351B2 (en) 2018-10-30 2024-06-25 Michael Foods, Inc. Crisped proteinaceous food product
US20240206509A1 (en) * 2022-12-22 2024-06-27 Clara Foods Co. Protein compositions and consumable products thereof
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
WO2024197288A1 (en) * 2023-03-22 2024-09-26 Clara Foods Co. Beverage clarification using recombinant ova or ovd
US12281290B2 (en) 2021-09-08 2025-04-22 Plantible Foods Inc. Systems and methods for measuring mat density of aquatic biomass
EP4401570A4 (en) * 2021-09-15 2025-07-16 Clara Foods Co SOURCES OF PROTEINS OF NON-ANIMAL ORIGIN WITH FUNCTIONAL PROPERTIES

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10305471B2 (en) 2016-08-30 2019-05-28 Micron Technology, Inc. Systems, methods, and apparatuses for temperature and process corner sensitive control of power gated domains
KR102938281B1 (ko) * 2023-08-30 2026-03-12 국립순천대학교산학협력단 천연유화소재를 이용한 식물성 비건용 마요네즈 및 그 제조 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180084814A1 (en) * 2015-03-27 2018-03-29 Kedar Challakere Synthetic avian-free egg white substitute and uses thereof
WO2018162557A2 (en) * 2017-03-07 2018-09-13 LIHME PROTEIN SOLUTIONS ApS Method for purifying proteins using silicate
US20180355020A1 (en) 2014-11-11 2018-12-13 Clara Foods Co. Methods and compositions for egg white protein production

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379174A (en) * 1979-09-06 1983-04-05 Batterlite-Whitlock Incorporated Dietetic cake mix
US4430428A (en) * 1980-02-05 1984-02-07 The Upjohn Company Composition of matter and process
US4655125A (en) * 1985-02-15 1987-04-07 Meiji Seika Kaisha, Ltd. Apparatus for producing baked products
US4717577A (en) * 1985-10-10 1988-01-05 Nabisco Brands, Inc. Producing multi-textured cookies containing gum
FI84970C (fi) * 1988-04-22 1992-02-25 Suomen Sokeri Oy Foerfarande foer foerbaettring av degens egenskaper och broedets kvalitet.
US6391366B1 (en) * 1999-12-10 2002-05-21 General Mills, Inc. Soft frozen batter for baked goods and method of preparation
US20070160728A1 (en) * 2005-10-13 2007-07-12 Noel Rudie Gluten-free food products including deflavored bean powder
MX389785B (es) * 2011-07-26 2025-03-18 Nucitec Sa De Cv Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.
US20130115358A1 (en) * 2011-09-29 2013-05-09 Catherine V. Seeley Baked food products prepared with carbonated liquids and methods of making the same
ES2858123T3 (es) * 2016-11-10 2021-09-29 Direct Food Ingredients Ltd Métodos de formación de productos de panadería a partir de mezclas en partículas
MX2016016695A (es) * 2016-12-15 2018-06-14 Com Teifaros S De R L Composición de harina base pasteles, libre de gluten.
WO2025163064A1 (en) 2024-01-31 2025-08-07 Vivici B.V. USE OF A β-LACTOGLOBULIN TO ENHANCE THE PHYSICAL STABILITY OF A PROTEIN COMPOSITION

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180355020A1 (en) 2014-11-11 2018-12-13 Clara Foods Co. Methods and compositions for egg white protein production
US20180084814A1 (en) * 2015-03-27 2018-03-29 Kedar Challakere Synthetic avian-free egg white substitute and uses thereof
WO2018162557A2 (en) * 2017-03-07 2018-09-13 LIHME PROTEIN SOLUTIONS ApS Method for purifying proteins using silicate

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "FT-R5851B Ovalbumin Product Information", INTERCHIM, 8 April 2009 (2009-04-08), XP055794978, Retrieved from the Internet <URL:http://www.interchim.fr/ft/R/R5851B.pdf> *
DATABASE UniprotKB 3 May 2011 (2011-05-03), "RecName: Full=Methionine aminopeptidase 2 {ECO:0000255|HAMAP-Rule:MF_03175}​;", XP055794969, Database accession no. C4R2P3 *
GODA SHUICHIRO, TAKANO KAZUFUMI, YAMAGATA YURIKO, KATAKURA YOSHIO, YUTANI KATSUHIDE: "Effect of extra N-terminal residues on the stability and folding of human lysozyme expressed in Pichia pastoris", PROTEIN ENGINEERING, vol. 13, no. 4, 2000, pages 299 - 307, XP055794971 *
ITO, K . ET AL.: "Structural characteristics of hen egg ovalbumin expressed in yeast Pichia pastoris", BIOSCIENCE, BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 69, no. 4, 2005, pages 755 - 761, XP055175533, DOI: 10.1271/bbb.69.755 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12016351B2 (en) 2018-10-30 2024-06-25 Michael Foods, Inc. Crisped proteinaceous food product
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US11800887B2 (en) 2019-07-11 2023-10-31 Clara Foods Co. Protein compositions and consumable products thereof
US11974592B1 (en) 2019-07-11 2024-05-07 Clara Foods Co. Protein compositions and consumable products thereof
US12241109B2 (en) 2020-09-30 2025-03-04 Nobell Foods, Inc. Host cells comprising a recombinant casein protein and a recombinant kinase protein
US12139737B2 (en) 2020-09-30 2024-11-12 Nobell Foods, Inc. Host cells comprising a recombinant casein protein and a recombinant kinase protein
US11685928B2 (en) 2020-09-30 2023-06-27 Nobell Foods, Inc. Recombinant fusion proteins for producing milk proteins in plants
US11840717B2 (en) 2020-09-30 2023-12-12 Nobell Foods, Inc. Host cells comprising a recombinant casein protein and a recombinant kinase protein
US11952606B2 (en) 2020-09-30 2024-04-09 Nobell Foods, Inc. Food compositions comprising recombinant milk proteins
US12077798B2 (en) 2020-09-30 2024-09-03 Nobell Foods, Inc. Food compositions comprising recombinant milk proteins
WO2022076615A1 (en) * 2020-10-06 2022-04-14 Clara Foods Co. Protein compositions and consumable products thereof
WO2022226176A3 (en) * 2021-04-23 2022-12-01 Plantible Foods Inc. Ribulose-1,5-bisphosphate carboxylate-oxygenase (rubisco) protein isolate compositions for plant-based egg replacement products and plant-based milk replacement products
US11718644B2 (en) 2021-07-23 2023-08-08 Clara Foods Co. Purified protein compositions and methods of production
CN117979833A (zh) * 2021-07-23 2024-05-03 克莱拉食品公司 纯化的蛋白组合物及生产方法
WO2023004153A1 (en) * 2021-07-23 2023-01-26 Clara Foods Co. Purified protein compositions and methods of production
EP4373289A4 (en) * 2021-07-23 2025-09-24 Clara Foods Co PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION THEREOF
US12281290B2 (en) 2021-09-08 2025-04-22 Plantible Foods Inc. Systems and methods for measuring mat density of aquatic biomass
EP4401570A4 (en) * 2021-09-15 2025-07-16 Clara Foods Co SOURCES OF PROTEINS OF NON-ANIMAL ORIGIN WITH FUNCTIONAL PROPERTIES
WO2023102214A1 (en) * 2021-12-03 2023-06-08 Mars, Incorporated Food product
WO2023148340A1 (fr) * 2022-02-03 2023-08-10 Algama Composition de substitution aux œufs pour la préparation d'un substitut végétalien à l'omelette ou aux œufs brouillés
US20240206509A1 (en) * 2022-12-22 2024-06-27 Clara Foods Co. Protein compositions and consumable products thereof
US12290088B2 (en) * 2022-12-22 2025-05-06 Clara Foods Co. Protein compositions and consumable products thereof
WO2024197288A1 (en) * 2023-03-22 2024-09-26 Clara Foods Co. Beverage clarification using recombinant ova or ovd

Also Published As

Publication number Publication date
AU2020331967A1 (en) 2022-03-17
DK182004B1 (en) 2025-05-20
DK202300015Y3 (da) 2023-07-03
GB2605017B (en) 2023-12-20
MX2022002051A (es) 2022-03-17
US20260020590A1 (en) 2026-01-22
EP4559323A3 (en) 2025-08-13
IL290550A (en) 2022-04-01
EP4017287A1 (en) 2022-06-29
JP2022546260A (ja) 2022-11-04
EP4017287B1 (en) 2024-12-11
BR112022003241A2 (pt) 2022-06-28
JP2025100711A (ja) 2025-07-03
HRP20250291T1 (hr) 2025-06-20
DK202300015U9 (da) 2024-07-05
CA3145805A1 (en) 2021-02-25
GB2621062A (en) 2024-01-31
DK202300015U1 (da) 2023-06-06
EP4017287A4 (en) 2023-08-09
DK202300015Y9 (da) 2024-07-05
DE202020005912U1 (de) 2023-10-13
KR20220047845A (ko) 2022-04-19
EP4017287C0 (en) 2024-12-11
DK202470291A1 (en) 2025-03-12
GB202203397D0 (en) 2022-04-27
US20220039443A1 (en) 2022-02-10
EP4559323A2 (en) 2025-05-28
ES3014359T3 (en) 2025-04-22
FI20225221A1 (en) 2022-03-12
CN114599234A (zh) 2022-06-07
FI13394Y1 (fi) 2023-06-06
GB2605017A (en) 2022-09-21
DK202270112A1 (en) 2022-03-30
US20230189857A1 (en) 2023-06-22
GB202317257D0 (en) 2023-12-27

Similar Documents

Publication Publication Date Title
US20260020590A1 (en) Non-animal based protein sources with functional properties
US20230329294A1 (en) Protein compositions and consumable products thereof
WO2021007565A1 (en) Protein compositions and consumable products thereof
AU2020309602A1 (en) Protein compositions and consumable products thereof
US20260078168A1 (en) Non-animal based protein sources with functional properties
US12096784B2 (en) Protein compositions and consumable products thereof
US20250333439A1 (en) Purified protein compositions and methods of production
HK40074680B (en) Non-animal based protein sources with functional properties
HK40074680A (en) Non-animal based protein sources with functional properties
US20250019396A1 (en) Recombinant protein recovery methods
US20250134130A1 (en) Recombinant protein recovery methods and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20855636

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3145805

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2022510139

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112022003241

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 202203397

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20200819

WWE Wipo information: entry into national phase

Ref document number: 2203397.1

Country of ref document: GB

WWP Wipo information: published in national office

Ref document number: 20225221

Country of ref document: FI

ENP Entry into the national phase

Ref document number: 20227009006

Country of ref document: KR

Kind code of ref document: A

Ref document number: 2020331967

Country of ref document: AU

Date of ref document: 20200819

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA202470291

Country of ref document: DK

Ref document number: PA202270112

Country of ref document: DK

ENP Entry into the national phase

Ref document number: 2020855636

Country of ref document: EP

Effective date: 20220321

WWP Wipo information: published in national office

Ref document number: PA202270112

Country of ref document: DK

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: 112022003241

Country of ref document: BR

Free format text: REAPRESENTE O CONTEUDO DA LISTAGEM DE SEQUENCIAS COM OS CAMPOS OBRIGATORIOS 140 / 141 E COM O CAMPO 151 NO FORMATO DD/MM/AAAA. RESSALTE-SE QUE PELO ART. 5O, DA PORTARIA 56, DE 27/12/2021, E FACULTADO OPTAR PELA ENTREGA DO CONTEUDO DA LISTAGEM DE SEQUENCIAS NO FORMATO ST.25 ATE 30/06/2022. APOS ESSA DATA, O UNICO FORMATO ACEITO SERA O ST.26.

ENP Entry into the national phase

Ref document number: 112022003241

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20220221

WWP Wipo information: published in national office

Ref document number: 2203397.1

Country of ref document: GB

WWD Wipo information: divisional of initial pct application

Ref document number: 2203397.1

Country of ref document: GB

Ref document number: 2317257.0

Country of ref document: GB

WWG Wipo information: grant in national office

Ref document number: 2203397.1

Country of ref document: GB

WWP Wipo information: published in national office

Ref document number: 2317257.0

Country of ref document: GB

WWP Wipo information: published in national office

Ref document number: PA202470291

Country of ref document: DK

WWG Wipo information: grant in national office

Ref document number: PA202270112

Country of ref document: DK

WWW Wipo information: withdrawn in national office

Ref document number: 20225221

Country of ref document: FI

WWC Wipo information: continuation of processing after refusal or withdrawal

Ref document number: 20225221

Country of ref document: FI